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Abstract—In mice, 249 putative members of the superfamily
of EF-hand domain Ca2+-binding proteins, manifesting
great diversity in structure, cellular localization and
functions have been identiﬁed. Three members in particular,
namely, calbindin-D28K, calretinin and parvalbumin,
are widely used as markers for speciﬁc neuronal
subpopulations in diﬀerent regions of the brain. The aim
of the present study was to compile a comprehensive atlas
of the gene-expression proﬁles of the entire EF-hand gene
superfamily in the murine brain. This was achieved by a
meticulous examination of the in-situ hybridization images
in the Allen Brain Atlas database. Topographically, our
analysis focused on the olfactory bulb, cerebral cortex
(barrel cortex in the primary somatosensory area), basal
ganglia, hippocampus, amygdala, thalamus, hypothalamus,
cerebellum, midbrain, pons and medulla, and on clearly
identiﬁable sub-structures within each of these areas. The
expression proﬁles of four family-members, namely
hippocalcin-like 4, neurocalcin-d, plastin 3 and tescalcin,
that have not been hitherto reported, at either the mRNA
(in-situ-hybridization) or the protein (immunohistochemical)
levels, are now presented for the ﬁrst time. The fruit of
our analysis is a document in which the gene-expression
proﬁles of all members of the EF-hand family genes
are compared, and in which future possible neuronal
markers for speciﬁc cells/brain areas are identiﬁed. The
assembled information could aﬀord functional clues to
investigators, conducive to further experimental pursuit.
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Abbreviations: ABA, Allen Brain Atlas; AMY, amygdala; AON, anterior olfactory nucleus; APN, anterior pretectal nucleus; ARH, arcuate hypothalamic
nucleus; AV, anteroventral nucleus of the thalamus; BG, basal ganglia; BLA, basolateral nucleus of the amygdala; BMA, basomedial nucleus of the
amygdala; CA1/2/3, Ammon’s horn regions 1/2/3; Calb1, Calb-D28K-encoding gene; Calb2, CalR-encoding gene; Calb-D28K, calbindin protein; CalR,
calretinin protein; CBX, cerebellum; CEA, central nucleus of the amygdala; CLA, claustrum; CM, central medial nucleus of the thalamus; COA, cortical
nucleus of the amygdala; CP, caudoputamen; CS, superior central raphe´ nucleus; CSm, superior-central raphe´, nucleus, medial part; CTX, cerebral
cortex; CUN, cuneiform nucleus; DCN, deep cerebellar nuclei; DG, dentate gyrus; DG sg, dentate gyrus, granule cell layer; DL, dorsolateral quadrant of
the PAG; DMH, dorsomedial hypothalamic nucleus; DMX, dorsal motor nucleus of the Vagus nerve; DR, dorsal raphe´ nucleus; DTN, dorsal tegmental
nucleus; EF-CaBP, EF-hand domain containing Ca2+-binding protein; END, endopiriform nucleus; EW, Edinger–Westphal nucleus; Golgi c., golgi
cells; GPE, globus pallidus, external segment; GPI, globus pallidus, internal segment; gl, glomerula layer of the olfactory bulb; gr, granular layer of the
olfactory bulb; Gr, granular layer of the cerebellum; Hpcal4/Hpcal4, respectively hippocalcin-like 4 gene/protein; HPF, hippocampus formation; HY,
hypothalamus; IC, inferior colliculus; III, oculomotor nucleus; IO, inferior olivary complex; ISH, in situ hybridization; IV, trochlear nucleus; LAV, lateral
vestibular nucleus; LC, locus coeruleus; LD, latero-dorsal nucleus of the thalamus; LDT, latero-dorsal tegmental nucleus; LGd, dorsal part of the
geniculate complex; LH, lateral habenula; LHA, lateral hypothalamic area; LM, lateral mammillary nucleus; LP, lateral posterior nucleus of the thalamus;
LRN, lateral reticular nucleus; LS, lateral septum; MARN, magnocellular reticular nucleus; MB, midbrain; ME, medial nucleus of the amygdala; MEV,
midbrain trigeminal nucleus; MH, medial habenula; mi, mitral cells layer, olfactory bulb; MM, medial mammillary nucleus; Mo, molecular layer of the
cerebellum; MS, medial septum; MV, medial vestibular nucleus; MY, medulla oblongata; Ncald/Ncald, repectively neurocalcin-d gene/protein; nd, not
detected; ND, nucleus of Darkschewitz; NDB, nucleus of the diagonal band; NLL, nucleus of the lateral lemniscus; NTB, nucleus of the trapezoid body;
NTS, nucleus of the solitary tract; OB, olfactory bulb; opl, outer plexiform layer, olfactory bulb; P, pons; PA, posterior nucleus of the amygdala; PAG,
periaqueductal gray; Parv, parvalbumin-protein; PBG, parabigeminal nucleus; PBl, parabrachial nucleus, lateral division; PCG, pontine central gray;
Pch, plexus choroideus; PCN, paracentral nucleus; pCTX, prefrontal cortex; PF, parafascicular nucleus; PFA, paraformaldehyde; PG, pontine gray;
PGRN, paragigantocellular nucleus; PH, posterior hypothalamic nucleus; Pls3, plastin3-encoding gene; PMd, dorsal premammillary nucleus; PRN,
pontine reticular nucleus; PRP, nucleus prepositus; PSV, principal sensory nucleus of the trigeminal; PT, parataenial nucleus; Pu, Purkinje cells layer;
PV1, PV1 nucleus; PV2, PV2 nucleus of the PAG; Pvalb, Parv-encoding gene; PVH, paraventricular hypothalamic nucleus; PVT, paraventricular
nucleus of the thalamus; RE, reunions nucleus; RH, rhomboid nucleus; RM, nucleus raphe´ magnus; RMS, rostral migratory stream; RN, red nucleus;
RT, reticular nucleus of the thalamus; S, striatum; SC, superior colliculus; SCH, suprachiasmatic nucleus; sg, granule cell layer, dentate gyrus; SI,
substantia innominata; SLD, sublatero-dorsal nucleus; SNc, substantia nigra, compact part; so, oriens layer of the hippocampus; sp, pyramidal layer of
the hippocampus; spa, sparse distribution of stained elements; SPIV, spinal nucleus of the trigeminus, interpolar part; SPV, spinal nucleus of the
trigeminal; STN, subthalamic nucleus; SUMI, supramammillary nucleus, lateral part; TBS, tris-buﬀered saline; Tesc/Tesc, respectively tescalcin gene/
protein; TH, thalamus; TM, tuberomammillary nucleus; TRN, tegmental reticular nucleus; ubi, ubiquitary distribution of stained elements; V, motor
nucleus of trigeminal nerve; VAL, ventral anterior nucleus of the thalamus; VI, abducens nucleus; VII, facial motor nucleus; Vl, lateral ventricle; VM,
ventral medial nucleus of the thalamus; VMH, ventro-medial hypothalamic nucleus; VPL, ventral postero-lateral nucleus of the thalamus; VPM, ventral
postero-medial nucleus of the thalamus; VTA, ventral tegmental area; VTN, ventral tegmental nucleus; Wm, white matter; XII, hypoglossal nucleus; ZI,
zona incerta.
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INTRODUCTION
Following the advent of the modern genome-sequencing
techniques, a number of studies were undertaken in
which the assimilated know-how was utilized to gain
insights into gene functions. The fruits of these
investigations are numerous published web databases,
which furnish information appertaining to, for example,
nomenclature, gene/protein sequences, protein/gene
interactions, expression patterns, biological activity,
integrated biological systems and disease-associations
in humans. One such large-scale genomic database –
the Allen Brain Atlas (ABA) database (http://www.brain-
map.org/) – yields information of inestimable value on
the expression patterns of genes in the adult murine
brain (Lein et al., 2007). These data have served as the
basis for more restricted analyses, which have focused,
for example, on the gene-expression proﬁling of particular
neuro-anatomical structures, gene families and non-cod-
ing RNAs (Sunkin and Hohman, 2007; Mercer et al.,
2008; Olszewski et al., 2008; Thompson et al., 2008;
Dahlin et al., 2009; Dong et al., 2009; Tebbenkamp and
Borchelt, 2010; Girard et al., 2011, 2014; Ko et al., 2013).
During the past three decades, three members of the
superfamily of EF-hand Ca2+-binding proteins (EF-
CaBPs), namely, calbindin-D28K (Calb-D28K) (Calb1
gene), calretinin (CalR) (Calb2 gene) and parvalbumin
(Parv) (Pvalb gene) have been widely used as speciﬁc
and robust markers for discrete, often GABAergic,
neuronal populations (Celio, 1990; Baimbridge et al.,
1992; Andressen et al., 1993; Bastianelli, 2003;
Schwaller, 2009, 2010). A classical example is the sub-
population of fast-spiking GABAergic, Parv-positive
interneurons existing in several diﬀerent brain regions
including the neocortex, striatum, hippocampus and cere-
bellum (Hu et al., 2014). More recently, secretagogin
(Scgn), a member of the family of hexa-EF-hand proteins
has been recruited as a neuro-morphological marker and
used to further characterize novel neuronal populations
(Alpar et al., 2012; Kosaka and Kosaka, 2013; Gati
et al., 2014; Romanov et al., 2015). An interesting
outcome of these studies is that Ca2+-binding proteins
do not necessarily delineate a uniform neuronal sub-
population. For example, Calb-D28K is expressed at low
levels in pyramidal neurons of cortical layers 2–3 and
CA1-pyramidal cells and at high levels in scattered
interneurons (Celio, 1990). CalR is expressed not only
in mature layer-2 GABAergic interneurons but also in
interneurons of the adult striatum (Ernst et al., 2014).
Although neurons expressing Parv also have diﬀerent
morphologies and distributions, as exempliﬁed by the
interneurons of the cerebral cortex and in the hippocam-
pus (DeFelipe et al., 2013), and by the long-axon neurons
such as the Purkinje cells of the cerebellum and the
oculomotor motoneurons of the midbrain (Solbach and
Celio, 1991), they share in common a high ﬁring rate
(Kawaguchi et al., 1987). Moreover, while the
developmental patterns of Calb-D28K-, CalR- and
Parv-expressing neurons in the neocortex are fairly
consistent between species, in other parts of the brain
and among mammalian orders, neurons expressing any
of these EF-CaBPs exhibit great diﬀerence in the
morphology and distribution (Hof et al., 1999). In the basal
forebrain for example, immunoreactivity for Calb-D28k
reveals the cholinergic cells of the basal forebrain only
in primates, not in rodents (Celio and Norman, 1985).
Furthermore, CalR and Calb-D28K are considered to be
useful markers for corticogenesis in humans since they
are expressed at very early embryonic stages
[(Carnegie stage (CS) 17 (Gonzalez-Gomes and Meyer,
2014)], namely during the phases that precede the
generation and the migration of the various interneuronal
subtypes. Proteins including CalR and other EF-CaBPs
have also proved to be useful in delineating the various
stages of adult hippocampal neurogenesis (Brandt
et al., 2003; Kempermann et al., 2004). During this
process, an active interchange in the expression of the
EF-CaBP takes place: CalR is expressed only transiently
in newly formed (glutamatergic) granule cells; in the more
mature ones it is replaced by Calb-D28K (Brandt et al.,
2003). The molecular basis for this switch remains an
enigma; we know only that in adult CalR-knockout mice
the absence of this protein leads to a permanent impair-
ment of neurogenesis (Todkar et al., 2012). The latter
ﬁnding also points to an important distinction: the expres-
sion of a given EF-CaBP in a well-deﬁned neuronal sub-
population permits an investigation not only of the role
of a particular protein in this group of cells, using for
instance transgenic or knockout animals, but it also allows
studying the role of the neuronal population itself, by
targeting it genetically – irrespective of the role the
EF-CaBP may play in this population. Studies of this
type include the use of transgenic mice expressing Cre-
recombinase under the control of the Pvalb-promoter
(Hippenmeyer et al., 2005). By means of optogenetic
experiments, in which the selective expression of the
hyperpolarizing halorhodopsin in Parv-positive nerve cells
is triggered, a suppression of c-oscillations in vivo was
demonstrated, whereas a channelorhodopsin-mediated
activations of this neuronal subpopulation leads to emer-
gent c-frequency rhythmicity (Sohal et al., 2009). This
ﬁnding is of some functional relevance, in so far as alter-
ations in either the function, the number or the mRNA/pro-
tein-expression level of Parv-immunoreactive neurons
correlates not only with experience-dependent plasticity
(Donato et al., 2013), but also with the manifestation of
neurological disturbances including schizophrenia, bipolar
disorder and autism (Lewis et al., 2005; Torrey et al.,
2005; Gogolla et al., 2009). In addition, chronic stress
down-regulates signiﬁcantly the expression of hippocam-
pal Parv (Hu et al., 2010; Filipovic et al., 2013).
The four summarized proteins (Calb-D28K, CalR,
Parv, Scgn) represent but a minute contingent of the
richly endowed superfamily to which they belong, which,
in eukaryotic organisms, is the most abundant category
of Ca2+-binding proteins. Hence, it would be of interest
to identify other potential neuronal markers within this
family. The conserved EF-hand domain consists of two
alpha helices, which are joined by a Ca2+-binding loop.
The canonical sequence is comprised of about 30
residues, and the EF-hand motifs commonly occur in
adjacent pairs (Kawasaki et al., 1998; Lewit-Bentley and
Rety, 2000). By 1990, 160 members of the EF-CaBP
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superfamily were identiﬁed. Following the publication of
mammalian genomes, the number rose to over 200, and
even this estimate was deemed to be a conservative
one (Persechini et al., 1989; Moncrief et al., 1990;
Haiech et al., 2004). EF-CaBPs play a central role in all
aspects of Ca2+ signaling, which include the control of
Ca2+ gating, modulation of the amplitude and duration
of Ca2+ signals and the transduction of Ca2+ signals into
biochemical responses. The involvement of the
EF-CaBPs in such a broad array of functions is rendered
possible by the great diversity that they manifest in
structure, cellular localization and molecular activity
(Schwaller, 2009, 2010).
It was the aim of the present study to map in the
murine brain the expression proﬁles of all members of
the EF-CaBP superfamily at the gene level by an
exhaustive analysis of the in-situ-hybridization data in
the ABA. Our analysis has revealed potential new
markers for speciﬁc neurons, as well as for certain brain
nuclei, areas and layers, and possibly also for speciﬁc
functional systems.
EXPERIMENTAL PROCEDURES
Bioinformatics
For listing the genes of the EF-hand super-family, we
searched the Uniprot database (http://www.uniprot.org/),
selecting the term ‘‘EF-hand’’ as query, as well as the
NCBI Gene database (http://www.ncbi.nlm.nih.gov/gene/),
selecting the terms ‘‘EF-hand’’ and ‘‘Mus musculus’’ as
queries. For analyzing gene expression patterns in
the mouse brain, we consulted the ABA database
(http://mouse.brain-map.org/), and examined available
in situ hybridization (ISH) images for each of the
EF-hand genes (see Table 2). The number of ISH-series
available in the ABA for the detection of the expression
of a given gene varies from 1 (sagittal series for 61
genes), 2 (sagittal + coronal series for 60 genes), 3 or
more (sagittal + coronal for 14 genes). (Table 2, 2nd
column: ISH Nr.). The schematic drawings in Figs. 1 and
2 were adapted from Dong (2008) and the ISH images
presented in Figs. 3–5 were taken from the ABA.
Animals
Adult mice (C57Bl6), males and females, aged
8–12 weeks, were used in this study for brain ISH and
immunostaining. Mice were housed in an animal facility
approved by the Veterinary Oﬃce of the Canton of
Fribourg (Switzerland), and according to the present
Swiss law and the European Communities Council
Directive of November 1986 (86/609/EC). Animals were
housed in groups of 3–5 individuals on a 12-h/12-h
light/dark cycle (light onset at 7 a.m.) with free access
to food and water. The study was approved by the
Veterinary Oﬃce of the Canton of Fribourg (Switzerland).
In situ hybridization
Total RNA from mouse brain (Zyagen, San Diego, USA)
was reverse transcribed using oligodT as primer, and
the reaction mixture was used as template for PCR
reactions using primers speciﬁc for each of the genes
tested (Pvalb, Ncald, Pls3, Eps15 and Sparcl1), the
sequence of which is described in the ABA database.
Forward and reverse primers were ﬂanked by T3 and
SP6 RNA polymerase core promoter sequence,
respectively (Girard et al., 2011). Digoxygenin-labeled
antisense and sense RNA probes were prepared from
each speciﬁc PCR template by in vitro transcription with
either SP6 or T3 RNA-polymerases and DIG-labeled
UTP (Roche Applied Science, Switzerland). Twelve-to-
fourteen micrometer coronal brain cryosections were pre-
pared on Superfrost gold slides (Medite, Nunningen,
Switzerland), and stored at 70 C until use. In situ
hybridization was performed essentially as previously
described (Girard et al., 2011), after ﬁxation of the brain
sections in 4% paraformaldehyde in PBS.
Immunostaining and antibodies
Immunostaining experiments were performed on 8-to-12-
week-old mouse brains, under standard conditions.
Animals were anesthetized with pentobarbital (100 mg/
kg), perfused through the left ventricle with ice-cold
0.9% NaCl, followed by ﬁxation with 4%
paraformaldehyde (PFA). Brains were excised, post-
ﬁxed overnight at 4 C in PFA, then immersed in 20%
sucrose solution in 0.1 M Tris buﬀer pH 7.3 (TBS) until
cryo-sectioning. Brains were cryo-sectioned into 30- or
40-lm coronal sections collected and maintained until
use in TBS containing 0.02% sodium azide.
Immunostaining experiments were performed following
standard protocols. Free-ﬂoating sections were
incubated 18–24 h at 4 C with primary antibodies
diluted in TBS containing 0.1% Triton-X100.
The following primary antibodies were used: anti-
hippocalcin-like 4 and anti-tescalcin (rabbit, 1/750, this
study), anti- neurocalcin-d (rabbit, 1/500 to 1/750, Enzo
Life Sci., Lausen, Switzerland), anti-parvalbumin (mouse
PV235 1/2’000, guinea pig PV690 1/1500 Swant, Marly,
Switzerland), anti-calbindin (mouse CB300, 1/2’000,
Swant, Marly, Switzerland), anti-calretinin (mouse
CR6B3, 1/2’000, Swant, Marly, Switzerland). Secondary
antibodies employed were Alexa 488-conjugated donkey
anti-rabbit (Luboscience, Luzern, Switzerland), Cy3-
conjugated donkey anti-mouse, Cy5-conjugated donkey
anti-guinea pig, Cy2- and Cy3-conjugated streptavidin
(Jackson Immunoresearch Laboratory, Rheinfelden,
Switzerland), biotinylated anti rabbit (Vector Laboratories,
Servion, Switzerland).
The image analysis was performed with a Zeiss
Axiophot ﬂuorescence microscope, a Hamamatsu
Nanozoomer and a Leica TCS SP5 confocal laser
microscope. Image post-processing and contrast
adjustments were performed with Adobe Photoshop and
Nanozoomer slide processing software.
Polyclonal antibodies to Hpcal4 and Tesc were
obtained the following way. In a larger and ongoing
project aiming to obtain reliable antibodies against all
EF-CaBPs, the selected cDNA sequences (for each of
the EF-CABP-encoding genes) were analyzed for both
CG content and the absence of BamHI and SalI
restriction sites. For each gene, cDNA was then
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Table 1. The EF-hand super-family in the mouse genome. For each EF-hand family gene, the abbreviated usual name, the complete name, and the
function of the encoded protein, according to Gene Ontology are given. The function in the CNS, when described (in italics), is mentioned. Genes in
bold show a detectable gene expression in the brain, according to the ABA data; (n.e.d): no expression detected in brain; (n.d): no data available in the
ABA database
Gene Complete name (alternative name) Gene ontology/CNS function(s)
Ankrd5 (n.e.d) Ankyrin repeat domain 5 (=Ankef1) Unknown
Actn1 Actinin, alpha 1 Actin ﬁlament binding/assembly; neurite extension
Actn2 (n.e.d) Actinin, alpha 2 Actin ﬁlament binding/assembly
Actn3 Actinin, alpha 3 Actin ﬁlament binding/assembly
Actn4 Actinin, alpha 4 Actin ﬁlament binding/assembly
Aif1 (n.e.d) Allograft inﬂammatory factor 1 (=Iba1) Actin ﬁlament binding/assembly
Aif1l (n.e.d) Allograft inﬂammatory factor 1-like Actin ﬁlament binding/assembly
Cabp1 Caldendrin, Ca2+-binding protein 1 Modulator of Ca2+ channel activity; Ca2+ sensor; ﬁne tuning
of CaV.1/2
Cabp2 (n.e.d) Ca2+-binding protein 2 Modulator of Ca2+ channel activity
Cabp4 Ca2+-binding protein 4 Modulator of Ca2+ channel activity
Cabp5 Ca2+-binding protein 5 Modulator of Ca2+ channel activity
Cabp7 Ca2+-binding protein 7 Modulator of Ca2+ channel activity
Calb1 Calbindin D-28 K Ca2+ sensor/buﬀer activity
Calb2 Calretinin Ca2+ sensor/buﬀer activity
Calm1 Calmodulin 1 Ca2+ sensor/Ca2+ signaling
Calm2 Calmodulin 2 Ca2+ sensor/Ca2+ signaling
Calm3 Calmodulin 3 Ca2+ sensor/Ca2+ signaling
Calm4 (n.e.d) Calmodulin 4 Ca2+ sensor/Ca2+ signaling
Calm5 (n.e.d) Calmodulin 5 Ca2+ sensor/Ca2+ signaling
Calml3 (n.e.d) Calmodulin-like 3 Ca2+ sensor/Ca2+ signaling
Calml4 (n.e.d) Calmodulin-like 4 Ca2+ sensor/Ca2+ signaling
Caln1 (n.e.d) Calneuron 1 Ca2+ buﬀer/sensor activity
Calu Calumenin Unknown
Capn1 Calpain 1 Ca2+-dependent cysteine-type endopeptidase activity;
neural stem cell renewal/diﬀerentiation
Capn2 Calpain 2 Ca2+-dependent cysteine-type endopeptidase activity;
modulator of gliogenesis
Capn3 Calpain 3 Ca2+-dependent cysteine-type endopeptidase activity
Capn8 Calpain 8 (=Capn10) Ca2+-dependent cysteine-type endopeptidase activity
Capn9 (n.e.d) Calpain 9 Ca2+-dependent cysteine-type endopeptidase activity
Capn11 (n.d) Calpain 11 Ca2+-dependent cysteine-type endopeptidase activity
Capn13 (n.e.d) Calpain 13 Ca2+-dependent cysteine-type endopeptidase activity
Capns1 Calpain, small subunit 1 Ca2+-dependent cysteine-type endopeptidase activity;
synaptic plasticity; traumatic brain injury
Capns2 (n.d) Calpain, small subunit 2 Ca2+-dependent cysteine-type endopeptidase activity
Caps2 (n.e.d) Calcyphosphine 2 Secretory granule exocytosis
Capsl (n.e.d) Calcyphosine-like Secretory granule exocytosis
Cbara1 Ca2+-binding atopy-related autoantigen 1 (=Micu1,
mitochondrial Ca2+ uptake 1)
Mitochondrial Ca2+ homeostasis
Cbl Casitas B-lineage lymphoma Ubiquitin ligase activity
Cblb Casitas B-lineage lymphoma b Ubiquitin ligase activity
Cblc (n.e.d) Casitas B-lineage lymphoma c Ubiquitin ligase activity
Ccdc48 (n.e.d) Coiled-coil domain containing 48 (=Efcc1, EF-hand and
coiled-coil domain containing 1)
Unknown
Cetn1 (n.e.d) Centrin 1 Microtubule dynamics
Cetn2 Centrin 2 Microtubule dynamics
Cetn3 Centrin 3 Microtubule dynamics
Cetn4 (n.e.d) Centrin 4 Microtubule dynamics
Cgref1 Cell growth regulator with EF hand domain 1 Unknown
Chp1 (n.d) Calcineurin-like EF-hand protein 1 Regulation of pH
Chp2 (n.e.d) Calcineurin-like EF-hand protein 2 Regulation of pH
Cib1 (n.e.d) Ca2+- and integrin-binding 1 (=calmyrin) Pleiotropous eﬀects
Cib2 Ca2+- and integrin-binding family member 2 (=Calmyrin
2)
Unknown
Cib3 (n.e.d) Ca2+- and integrin-binding family member 3 Unknown
Cib4 (n.d) Ca2+- and integrin-binding family member 4 Unknown
Crnn (n.d) Cornulin Unknown
Dgka Diacylglycerol kinase, alpha Diacylglycerol kinase activity
Dgkb Diacylglycerol kinase, beta Diacylglycerol kinase activity
(continued on next page)
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Table 1 (continued)
Gene Complete name (alternative name) Gene ontology/CNS function(s)
Dgkg Diacylglycerol kinase, gamma Diacylglycerol kinase activity
Dmd (n.e.d) Dystrophin Muscle cell structure/homeostasis
Drp2 Dystrophin-related protein 2 Muscle cell structure/homeostasis
Dst (n.e.d) Dystonin Cytoplasmic microtubule organization/axonogenesis
Dtna Dystrobrevin alpha Muscle homeostasis
Dtnb Dystrobrevin beta Muscle homeostasis
Duox1 (n.e.d) Dual oxidase 1 Oxidoreductase activity
Duox2 (n.d) Dual oxidase 2 Oxidoreductase activity
Dytn (n.e.d) Dystrotelin Muscle homeostasis
Efcab1 EF hand Ca2+-binding domain 1 Unknown
Efcab2 (n.e.d) EF-hand Ca2+-binding domain 2 Unknown
Efcab3 (n.e.d) EF-hand Ca2+-binding domain 3 Unknown
Efcab4a EF-hand Ca2+-binding domain 4A Ca2+ sensor activity
Efcab4b (n.e.d) EF-hand Ca2+-binding domain 4B Unknown
Efcab5 (n.e.d) EF-hand Ca2+-binding domain 5 Unknown
Efcab6 (n.d) EF-hand Ca2+-binding domain 6 Unknown
Efcab7 (n.d) EF-hand Ca-binding domain 7 Unknown
Efcab8 (n.d) EF-hand Ca2+-binding domain 8 Unknown
Efcab9 (n.e.d) EF-hand Ca2+-binding domain 9 Unknown
Efcab10 (n.e.d) EF-hand Ca2+-binding domain 10 Unknown
Efcab11 (n.e.d) EF-hand Ca2+-binding domain 11 (=Egfem1, EGF-like
and EMI domain containing 1)
Unknown
Efcab12 EF-hand Ca2+-binding domain 12 (=BC060267) Unknown
Efcab14 (n.d) EF hand Ca2+-binding domain 14 Unknown
Efha1 (n.e.d) EF hand domain family A1 (=Micu2, mitochondrial Ca2+
uptake 2)
Mitochondrial Ca2+ homeostasis
Efha2 EF-hand domain family, member A2 (=Micu3,
mitochondrial Ca2+ uptake 3)
Mitochondrial Ca2+ homeostasis
Efhb EF hand domain family, member B Unknown
Efhc1 (n.e.d) EF-hand domain (C-terminal) containing 1 Unknown
Efhc2 (n.e.d) EF-hand domain (C-terminal) containing 2 Unknown
Efhd1 (n.e.d) EF hand domain containing 1 Unknown
Efhd2 EF hand domain containing 2 (=Swiprosin-1) B cell receptor signaling, kinesin-mediated transport in
neurites
Ehd1 EH-domain containing 1 Endocytosis; axonal targeting
Ehd2 EH-domain containing 2 Endocytosis
Ehd3 EH-domain containing 3 Endocytosis
Ehd4 (n.e.d) EH-domain containing 4 Endocytosis
Eps15 Epidermal growth factor receptor pathway substrate 15 Endocytosis
Eps15l1 Epidermal growth factor receptor pathway substrate 15-
like 1
Endocytosis
Fkbp7 (n.e.d) FK506-binding protein 7 Peptidyl-prolyl cis–trans isomerase activity
Fkbp9 FK506-binding protein 9 Peptidyl-prolyl cis–trans isomerase activity
Fkbp10 FK506-binding protein 10 Peptidyl-prolyl cis–trans isomerase activity
Flg (n.d) Filaggrin Cytoskeleton organization
Flg2 (n.d) Filaggrin family member 2 Unknown
Fstl1 Follistatin-like 1 BMP antagonist
Fstl4 Follistatin-like 4 (=Spig1) Unknown; negative regulator of BDNF maturation
Fstl5 Follistatin-like 5 Unknown
Gca Grancalcin Leukocyte adhesion
Gpd2 Glycerol phosphate dehydrogenase 2, mitochondrial Glycerol-3-phosphate dehydrogenase activity
Guca1a (n.e.d) Guanylate cyclase activator 1a Ca2+-sensitive guanylate cyclase activator activity, Ca2+
sensor activity
Guca1b Guanylate cyclase activator 1B Ca2+-sensitive guanylate cyclase activator activity, Ca2+
sensor activity
Hpca Hippocalcin Ca2+ sensor activity
Hpcal1 Hippocalcin-like 1 (=Vilip3) Ca2+ sensor activity
Hpcal4 Hippocalcin-like 4 (=Vilip2) Ca2+ sensor activity
Hrnr (n.e.d) Hornerin Unknown
Itsn1 Intersectin 1 (SH3 domain protein 1A) Guanyl-nucleotide exchange factor activity; synaptic vesicle
recycling
Itsn2 Intersectin 2 Guanyl-nucleotide exchange factor activity; synaptic vesicle
recycling
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Table 1 (continued)
Gene Complete name (alternative name) Gene ontology/CNS function(s)
Kcnip1 kV channel-interacting protein 1 (=Kchip1) Ca2+ sensor activity; modulation of Kv4 activity/control of
neuronal excitability
Kcnip2 kV channel-interacting protein 2 (=Kchip2) Ca2+ sensor activity; modulation of Kv4 activity/control of
neuronal excitability
Kcnip3 kV channel-interacting protein 3 (=Kchip3, DREAM,
calsenilin)
Transcription factor (repressor)
Kcnip4 kV channel-interacting protein 4 (=Kchip4) Ca2+ sensor activity; modulation of Kv4 activity/control of
neuronal excitability
Lcp1 Lymphocyte cytosolic protein 1 Actin ﬁlament bundle assembly
Letm1 Leucine zipper-EF-hand containing transmembrane
protein 1
Mitochondrial Ca2+ antiporter
Letm2 (n.e.d) Leucine zipper-EF-hand containing transmembrane
protein 2
Mitochondrial Ca2+ antiporter
Lpcat1 (n.e.d) Lysophosphatidylcholine acyltransferase 1 1-Acylglycerophosphocholine O-acyltransferase activity
Lpcat2 Lysophosphatidylcholine acyltransferase 2 1-Acylglycerophosphocholine O-acyltransferase activity
Lpcat2b (n.e.d) Lysophosphatidylcholine acyltransferase 2B Lysophosphatidylcholine acyltransferase activity
Macf1 Microtubule-actin crosslinking factor 1 Cytoskeletal organization; neuronal migration during
development
Mcc Mutated in colorectal cancers Wnt receptor signaling pathway
Mcfd2 Multiple coagulation factor deﬁciency 2 Unknown; survival factor for neural stem cells
Myl1 Myosin, light polypeptide 1 Motor activity
Myl2 (n.e.d) Myosin, light polypeptide 2 Motor activity
Myl3
(unexploitable
data)
Myosin, light polypeptide 3 Motor activity
Myl4 Myosin, light polypeptide 4 Motor activity
Myl6 Myosin, light polypeptide 6 Motor activity
Myl6b (n.e.d) Myosin, light polypeptide 6B Motor activity
Myl7 (n.e.d) Myosin, light polypeptide 7 Motor activity
Myl9 (n.e.d) Myosin, light polypeptide 9, Motor activity
Myl12a (n.e.d) Myosin, light chain 12A, regulatory, non-sarcomeric
(=2900073G15Rik)
Motor activity
Myl12b (n.e.d) Myosin light chain, regulatory B Motor activity
Mylc2pl (n.d) Myosin light chain 2, precursor lymphocyte-speciﬁc Motor activity
Mylpf Myosin light chain, phosphorylatable, fast skeletal muscle Motor activity
Ncald Neurocalcin delta Ca2+ sensor activity
Ncs1 Neuronal Ca2+ sensor1 (=frequenin homolog) Ca2+ sensor activity; modulation of synaptic plasticity/
neuronal secretion
Necab1 N-terminal EF-hand Ca2+-binding protein 1 Unknown
Necab2 N-terminal EF-hand Ca2+-binding protein 2 Unknown
Necab3 N-terminal EF-hand Ca2+-binding protein 3 Unknown
Nin Ninein Microtubule dynamics
Ninl (n.d) Ninein-like Microtubule dynamics
Nkd1 Naked cuticle 1 homolog Wnt receptor signaling pathway
Nkd2 Naked cuticle 2 homolog Wnt receptor signaling pathway
Nucb1 Nucleobindin 1 Ca2+ storage regulation in Golgi
Nucb2 Nucleobindin 2 (=Nesfatin) Three diﬀerent peptides (neuropeptide/DNA binding/Ca2+
binding)
Ocm (n.e.d) Oncomodulin Ca2+ buﬀer activity
P4htm Prolyl 4-hydroxylase, transmembrane Oxidoreductase activity
Pdcd6 Programed cell death 6 (=Alg2) Apoptosis
Pef1 Penta-EF hand domain containing 1 Unknown
Pkd2 Polycystic kidney disease 2 Ca2+ channel activity
Pkd2l1 (n.e.d) Polycystic kidney disease 2-like 1 Cation channel activity
Plcd1 (n.e.d) Phospholipase C, delta 1 Phosphoinositide phospholipase C activity
Plcd4 (n.d) phospholipase C, delta 4 Phosphoinositide phospholipase C activity
Plcg1 Phospholipase C, gamma 1 Phosphoinositide phospholipase C activity
Plch1 Phospholipase C, eta 1 Phosphoinositide phospholipase C activity; Ca2+ sensor
activity
Plch2 Phospholipase C, eta 2 Phosphoinositide phospholipase C activity
Plcz1 (n.e.d) Phospholipase C, zeta 1 Phosphoinositide phospholipase C activity
Pls1 (n.e.d) Plastin 1 (I-isoform) Actin ﬁlament binding/assembly
Pls3 Plastin 3 (T-isoform) Actin ﬁlament binding/assembly
(continued on next page)
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Table 1 (continued)
Gene Complete name (alternative name) Gene ontology/CNS function(s)
Ppef1 (n.e.d) Protein phosphatase with EF hand Ca2+-binding domain
1
Protein serine/threonine phosphatase activity
Ppef2 (n.e.d) Protein phosphatase, EF hand Ca2+-binding domain 2 Protein serine/threonine phosphatase activity
Ppp2r3a (n.e.d) Protein phosphatase 2, regulatory subunit B’’, alpha Protein phosphatase activity
Ppp2r3c Protein phosphatase 2, regulatory subunit B’’, gamma Protein phosphatase activity
Ppp2r3d Protein phosphatase 2, regulatory subunit B’’, delta Protein phosphatase activity
Ppp3r1 Protein phosphatase 3, regulatory subunit B, alpha isoform
(=calcineurin B, type I)
Protein phosphatase activity; regulation of synaptic
transmission/plasticity
Ppp3r2 (n.e.d) Protein phosphatase 3, regulatory subunit B, alpha isoform
(=calcineurin B, type II)
Protein phosphatase activity
Prkcsh Protein kinase C substrate 80 K-H Ca2+ sensor activity
Pvalb Parvalbumin Ca2+ sensor/buﬀer activity
Rab11ﬁp3 RAB11 family-interacting protein 3 Cell signaling
Rab11ﬁp4 RAB11 family-interacting protein 4 Cell signaling
Rasef (n.e.d) RAS and EF hand domain containing Cell signaling
Rasgrp1 RAS guanyl-releasing protein 1 Guanyl-nucleotide exchange factor activity
Rasgrp2 RAS, guanyl-releasing protein 2 Guanyl-nucleotide exchange factor activity
Rasgrp3 (n.e.d) RAS, guanyl-releasing protein 3 Guanyl-nucleotide exchange factor activity
Rcn1 Reticulocalbin 1 Unknown
Rcn2 Reticulocalbin 2 Unknown
Rcn3 (n.e.d) Reticulocalbin 3 Unknown
Rcvrn Recovering Ca2+ buﬀer activity in phototransduction; Ca2+ sensor
activity
Reps1 RalBP1-associated Eps domain containing protein Cell signaling
Reps2 RalBP1-associated Eps domain containing protein 2 Cell signaling
Rhbdl3 Rhomboid, veinlet-like 3 Peptidase activity
Rhot1 Ras homolog gene family, member T1 (=Miro1) GTPase activity; Ca2+ sensor activity /mitochondrial
traﬃcking in neurons
Rhot2 Ras homolog gene family, member T2 (=Miro2) GTPase activity
Rptn Repetin Unknown
Ryr1 Ryanodine receptor 1 ryanodine-sensitive Ca2+-release channel activity
Ryr2 Ryanodine receptor 2, cardiac ryanodine-sensitive Ca2+-release channel activity
S100a1 (n.e.d) S100 Ca2+-binding protein A1 Ca2+ buﬀer activity
S100a3 (n.e.d) S100 Ca2+-binding protein A3 Ca2+ buﬀer activity
S100a4 (n.e.d) S100 Ca2+-binding protein A4 Ca2+ buﬀer activity
S100a5 (n.e.d) S100 Ca2+-binding protein A5 Ca2+ buﬀer activity
S100a6 (n.e.d) S100 Ca2+-binding protein A6 (=calcyclin) Ca2+ buﬀer activity
S100a7a (n.e.d) 100 Ca2+-binding protein A7A Ca2+ buﬀer activity
S100a8 (n.e.d) S100 Ca2+-binding protein A8 (=calgranulin A) Ca2+ buﬀer activity
S100a9 S100 Ca2+-binding protein A9 (=calgranulin B) Ca2+ buﬀer activity; neuro-inﬂammatory process
S100a10 S100 Ca2+-binding protein A10 (=calpactin) Ca2+ buﬀer activity; serotonergic signaling
S100a11 S100 Ca2+-binding protein A11 (=calgizzarin) Ca2+ buﬀer activity
S100a13 (n.e.d) S100 Ca2+-binding protein A13 Ca2+ buﬀer activity
S100a14 (n.e.d) S100 Ca2+-binding protein A14 Ca2+ buﬀer activity
S100a16 S100 Ca2+-binding protein A16 Ca2+ buﬀer activity
S100b S100 protein, beta polypeptide, neural Ca2+ buﬀer activity; biological marker of brain damage
S100g (n.e.d) S100 Ca2+-binding protein G Ca2+ buﬀer activity
S100z (n.d) S100 Ca2+-binding protein, zeta Ca2+ buﬀer activity
Scgn Secretagogin Ca2+ sensor/buﬀer activity
Sdf4 Stromal cell-derived factor 4 Unknown
Slc25a12 Solute carrier family 25 (mitochondrial glutamate/aspartate
carrier), member 12 (=Aralar)
Transporter activity
Slc25a13 (n.e.d) Solute carrier family 25 (mitochondrial carrier, adenine
nucleotide translocator), member 13
Transporter activity
Slc25a23 Solute carrier family 25 (mitochondrial carrier; phosphate
carrier), member 23
Transporter activity
Slc25a24 (n.e.d) Solute carrier family 25 (mitochondrial carrier, phosphate
carrier), member 24
Transporter activity
Slc25a25 (n.e.d) Solute carrier family 25 (mitochondrial carrier, phosphate
carrier), member 25
Transporter activity
Smoc1 SPARC related modular Ca2+-binding 1 Extracellular matrix organization
Smoc2 SPARC related modular Ca2+-binding 2 Extracellular matrix organization
Sntn (n.e.d) Sentan, cilia apical structure protein Microtubule dynamics
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synthesized in vitro (Euroﬁns MWGOperon, Ebersberg,
Germany), with the addition of a 6xHis C-terminal tail
and BamH1/Sal1 restriction sequences at the
extremities, and further cloned into a variety of standard
vectors (pCR2.1, pUC57, pEX-A, pSK+). All plasmids
generated at Euroﬁns were digested with BamHI and
SalI and each excised insert independently ligated into
the expression plasmid pGEX-4P-1. The recombinant
plasmids were double checked by restriction analysis
and sequencing, and transformed into the Escherichia
coli strain JM109 for protein expression under control of
an IPTG inducible promoter. Proteins expressed in
Table 1 (continued)
Gene Complete name (alternative name) Gene ontology/CNS function(s)
Sparc secreted acidic cysteine rich glycoprotein (=osteonectin) Extracellular matrix organization; astrocyte-regulated
synaptogenesis
Sparcl1 SPARC-like 1 (=hevin) Extracellular matrix organization
Spata21 (n.e.d) Spermatogenesis-associated 21 Unknown
Spna1 (n.e.d) Spectrin alpha 1 Cytoskeletal organization
Spna2 Spectrin alpha 2 Cytoskeletal organization
Spock1 Sparc/osteonectin, cwcv and kazal-like domains
proteoglycan 1
Extracellular matrix organization
Spock2 Sparc/osteonectin, cwcv and kazal-like domains
proteoglycan 2
Extracellular matrix organization
Spock3 Sparc/osteonectin, cwcv and kazal-like domains
proteoglycan 3
Extracellular matrix organization
Sri Sorcin Intracellular Ca2+ transport; modulator of ryanodine-
sensitive Ca2+ -release channel
Stim1 Stromal interaction molecule 1 Ca2+ sensor activity; Ca2+ signaling/storage/release
Stim2 Stromal interaction molecule 2 Ca2+ sensor activity
Synrg (n.e.d) Synergin, gamma Unknown
Tchh (n.d) Trichohyalin Cytoskeletal organization
Tchhl1 Trichohyalin-like 1 (=S100a17) Unknown
Tesc Tescalcin (=calcineurin-like protein 3) Unknown
Tescl (n.d) Tescalcin-like Unknown
Tnnc1 Troponin C, cardiac/slow skeletal Actin ﬁlament binding/assembly
Tnnc2 (n.e.d) Troponin C2, fast Actin ﬁlament binding/assembly
Usp32 Ubiquitin-speciﬁc peptidase 32 Peptidase activity
Utrn Utrophin Muscle homeostasis
Vsnl1 Visinin-like 1 (=Vilip-1) Ca2+ sensor activity; regulator of receptors (P2X, glycine,
nicotinic acteylcholine)
Zzef1 Zinc ﬁnger, ZZ-type with EF hand domain 1 Unknown
1500003O03Rik RIKEN cDNA 1500003O03 gene (=calcineurin-like
protein 1)
Unknown
1700008P20Rik
(n.e.d)
RIKEN cDNA 1700008P20 gene Unknown
1700023F06Rik
(n.e.d)
RIKEN cDNA 1700023F06 gene Unknown
1700109H08Rik
(n.e.d)
RIKEN cDNA 1700109H08 gene Unknown
2010110P09Rik
(n.e.d)
RIKEN cDNA 2010110P09 gene (=calcineurin B
homologous protein 2)
Unknown
4732418C07Rik RIKEN cDNA 4732418C07 gene Unknown
4930443G12Rik
(n.e.d)
RIKEN cDNA 4930443G12 gene Unknown
9130204L05Rik
(n.e.d)
RIKEN cDNA 9130204L05 gene Unknown
Gm1254 (n.e.d) Predicted gene 12854 (=S100A11-like) Unknown
Gm2446 (n.d) Predicted gene 2446 Unknown
Gm5849 (n.d) Predicted gene 5849 Unknown
Gm5958 (n.d) Predicted gene 5958 Unknown
Gm9229 (n.d) Predicted gene 9229 Unknown
Gm20056 (n.d) Predicted gene 20056 Unknown
LOC101056100
(n.d)
Centrin-1-like Unknown
LOC100861614
(n.d)
Hippocalcin-like protein 1-like Unknown
LOC101055809
(n.d)
Ca2+ and integrin-binding family member 4-like Unknown
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distinct brain areas: main olfactory bulb (OB), cerebral cortex (CTX), Basal ganglia (BG), hippocampal formation (HPF), amygdala (AMY), thalamus (TH), hypothalamus (HY), midbrain (MB), pons (P),
cerebellum (CBX), medulla (MY).+: corresponds to a measurable expression; nd: no expression detected. The ISH signal was considered as positive when observed in several sections in a given structure.
For S100a11 the OB area is missing in the ABA database. Pu identiﬁes the Purkinje cell layer of the cerebellum. In this layer the main neuron is the Purkinje cell, but Golgi-epithelial cells (Bergmann-glia),
Golgi-interneurons and Lugaro cells can occur in the same plane. Therefore, Pu does not always automatically imply that the expressing cell is the Purkinje neuron. ‘‘Railroad-track’’ describes two parallel
continuous lines of stained cells in the Purkinje-cells layer and at the boundary between granular layer and white matter (Wm). Puﬀs indicate an accumulation of signal at the apex of cerebellar circumvolutions.
Mol: molecular layer; Pu: Purkinje-cells layer; Gr: granular layer. In addition, some sites (i.e. identiﬁable nuclei) of stronger or speciﬁc expression are listed in brackets (see the list of abbreviations). The term
‘‘scattered cells’’ is used when numerous cells expressing the gene of interest are scattered throughout the structure under consideration (in this situation, nuclei are identiﬁable). The term ‘‘sparse cells’’ is
used when only few cells in the area considered express the gene of interest, and when no nuclei are identiﬁable. For 22 genes, expression and localization studies have been performed by in-situ hybridization
or immunohistochemistry (numbered in column 1). 1(Kim et al., 2014), 2(Vasiljevic et al., 2012) 3(Konig et al., 2003), 4(Blazejczyk et al., 2009), 5(Dixon et al., 1997), 6(Bohm et al., 2008), 7(Yang et al., 2009),
8(Masuda et al., 2014), 9(Saitoh et al., 1993), 10(Xiong et al., 2004), 11(Bhat et al., 1994), 12(Zhang et al., 2014), 13(Sugita et al., 2002), 14(Kanemaru et al., 2010), 15(Meyer, 2014), 16(Kuwajima et al., 1992),
17(Sah et al., 1993), 18(Sturchler et al., 2006), 19(Vives et al., 2003), 20(Mulder et al., 2010), 21(Skibinska-Kijek et al., 2009), 22(Saitoh et al., 1994)
Gene name ISH
Nr
Marker Telencehalon Diencephalon Mesencephalon Metencephalon Myelencephalon
OB CTX BG HPF AMY Thalamus
(TH)
Hypothalamus
(HY)
Midbrain (MB) Pons (P) Cerebellum
(CBX)
DCN Medulla
oblongata (MY)
Actn1 1 + + + + + Scattered
cells
Scattered cells Scattered cells Scattered cells Gr nd + (Pch++)
Actn3 1 + + + + nd Scattered
cells
Scattered cells Scattered cells + Pu + +
Actn4 1 + + nd + + nd nd nd + (PG) Pu nd nd
Cabp11 1 + + nd + nd nd nd nd nd Mol, Pu, Gr + Scattered cells
Cabp4 1 + nd nd + nd nd nd nd nd Pu, Gr (railroad
track)
+ Scattered cells
Cabp5 1 + nd + + nd nd nd nd nd Pu, Gr nd nd
Cabp7 1 nd nd + + nd nd + (LM, ZI) + (III, ND, APN,
RN)
+ (PG, TRN) Pu, Gr ++ + (VI, VII, PRP,
XII, PGRN)
Calb1 20 v + + + + + + (VM, RE,
MH, PF)
+ (VMH,
DMH, PMd)
+ (VTA, EW, DR) + (NTB) Pu + + (MARN, IO,
SPV, NTS)
Calb2 17 v + + nd + + + (PVT,
RH, RE and
more)
Scattered cells + (SC, VTA, PAG:
DL and VL++)
+ (PG, TRN and
more)
Gr nd + (IO and more)
Calm1 3 Ub + + + + + Ubiquitous Ubiquitous Ubiquitous (III, DR) Ubiquitous Pu, Gr ++ Ubiquitous
Calm2 2 Ub + + + + + Ubiquitous Ubiquitous Ubiquitous (III, DR) Ubiquitous Pu, Gr + Ubiquitous
Calm3 1 + + nd + + Sparse cells
(weak)
Sparse cells
(weak)
+ (RN, MEV, III) + (PG, TRN) Few Pu and Gr + +
Calu2 1 + nd nd + nd nd nd nd nd Pu + Sparse cells
(weak)
Capn1 1 nd nd nd + nd nd nd III, IV, TRN + (PG, TRN, V) nd (+) + VII, LRN, XII,
NTS and
scattered cells
Capn2 3 + + + + (+) + (RT, AD
and
scattered
cells)
Sparse cells
(weak)
+ (RN, EW, MEV,
ND; III, IV, V)
+ (PG, TRN, NTB,
V)
Pu + + VI, VII, XII
and scattered
cells
Capn33 1 + + nd + nd + nd Sparse cells
(weak)
Sparse cells (weak) Pu, Gr (+) +
Capn 8 (10) 2 + + + + (+) + Sparse cells
(weak)
Sparse cells
(weak)
Sparse cells (weak) Pu (+) Sparse cells
(weak)
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Capns1 2 Ub + + + + + Ubiquitous Ubiquitous Ubiquitous (III, V,
DR)
Ubiquitous Pu, Gr ++ Ubiquitous
Cbara1 2 + + + + + + Scattered cells + (RN, EW, DR,
PAG, MEV, III)
+ (PG, V, TRN) Pu, Gr + Ubiquitous
strong
Cbl 1 nd nd nd + nd nd nd nd nd nd nd nd
Cblb 1 nd + nd + nd nd nd nd nd Gr nd nd
Cetn2 2 + + + + + Sparse cells
(weak)
Sparse cells
(weak)
nd Sparse cells (weak) Pu + Sparse cells
(weak)
Cetn3 2 nd nd nd + + nd nd nd nd Pu nd nd
Cgref1 1 nd nd + + + + (AD,
PVT)
Scattered cells Scattered cells + (PCG) Gr (+) + (VII)
Cib24 1 + + + + nd + (AD, PVT
and
scattered
cells)
+ + + nd nd + (LC)
Dgka 4 nd nd nd + nd nd nd nd nd nd nd nd
Dgkb 3 + + + + + + (RT, MH) + (MM, SUMI,
TM and
scattered cells)
Scattered cells,
DR
+ (LC) Pu (rare cells in
Gr)
(+) Scattered cells
Dgkg 3 + + + + + AD, RT + nd + (PG, TRN) Pu nd nd
Drp25 1 + + + + + + (weak) + (weak) + (weak) + (weak) Pu, Gr (railroad
track)
+ + (weak)
Dtna6 2 + + + + + + (weak) + (weak) + (DR strong and
scattered cells)
+ (TRN and
scattered cells)
Pu, Gr + + (VII and
scattered cells)
Dtnb 2 Ub + + + + + Ubiquitous Ubiquitous Ubiquitous Ubiquitous Pu (Rare sp in
Gr)
+ Ubiquitous
Efcab1 1 nd nd nd + (+) nd Sparse cells
(weak)
nd nd nd nd nd
Efcab4a 1 + + nd + nd nd nd nd + Pu (rare cells in
Gr)
nd +
Efha2 1 nd + nd + nd nd nd nd nd Pu (+) Sparse cells
(weak)
Efhb 1 + + nd + nd nd nd nd nd Pu nd nd
Efhd2 1 + + + + + + + + (RN and
scattered cells)
+ (PG, TRN and
scattered cells)
Pu (rare cells in
Gr)
+ + (LRN and
scattered cells)
Ehd1 1 nd + nd + nd nd nd nd nd Pu, Gr + nd
Ehd2 3 + + + + nd Sparse cells
(weak)
Sparse cells
(weak)
Sparse cells
(weak)
Sparse cells (weak) Pu, Gr + Sparse cells
(weak)
Ehd3 2 + + nd + + + (AD, VAL,
LD, PF)
Sparse cells
(weak)
+ (MEV, ND, RN,
III)
+, LC Pu, Gr ++ + (VII, XII, LRN)
Eps15 2 + + + + + Ubiquitous + Ubiquitous (DR) Ubiquitous (LC, PG,
TRN, strong)
Mol, Pu, Gr + Ubiquitous
Eps15l1 2 + + + + + Scattered
cells
Scattered cells Scattered cells Scattered cells Pu, Gr + Scattered cells
Fkbp9 2 + + + + nd Sparse cells Sparse cells nd Sparse cells Pu, Gr + Sparse cells
Fkbp10 2 + + nd + nd nd Sparse cells nd Sparse cells Pu, Gr + Scattered cells
Fstl17 2 + + + + + + (AD, PVT
and
scattered
Sparse cells + (RN, III, DR,
MEV, IV, V, VTN)
+ (PG, NLL, V,
TRN, NTB)
Gr +++ + (VI, VII, XII,
IO, PGRN, LRN)
(continued on next page)
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Gene name ISH
Nr
Marker Telencehalon Diencephalon Mesencephalon Metencephalon Myelencephalon
OB CTX BG HPF AMY Thalamus
(TH)
Hypothalamus
(HY)
Midbrain (MB) Pons (P) Cerebellum
(CBX)
DCN Medulla
oblongata (MY)
cells)
Fstl4 2 + + nd + + + (VAL,
VPM/VPL,
VM, weak)
nd + (III, IV weak) nd Pu nd nd
Fstl58 2 + nd nd + + nd nd PV2 + (LC) nd nd nd
Gca 2 nd + nd + nd nd nd nd nd nd nd nd
Gpd2 2 + + nd + + nd + (VMH) Sparse cells, DR.
LC
Sparse cells Gr nd Scattered cells
Guca1b 1 + + + + + Sparse cells Scattered cells nd Scattered cells Gr + Scattered cells
Hpca9 2 + + + + + + (RT and
Sparse cells)
Ubiquitous Ubiquitous + (LC and scattered
cells)
Mol, Pu, Gr (+) + (IO and
scattered cells)
Hpcal1 2 + nd + + + + (RT and
Sparse cells)
Scattered cells Scattered cells,
DR, LC
(rostrocaudal
changing pattern)
Sparse cells Pu nd + (IO, DMX and
scattered cells)
Hpcal4 2 v + + + + + + (PVT,
RE)
+ (VMH) + (DR, VTA) + (LC) Gr nd + (NTS)
Itsn1 2 Ub + + + + + Ubiquitous Ubiquitous Ubiquitous Ubiquitous Pu, Gr + Ubiquitous
Itsn2 2 + nd nd + nd nd nd nd nd nd nd Sparse cells
Kcnip110 2 V + + (+) + + + (RT, MH,
part LP, PT)
nd Sparse cells, MEV Sparse cells Pu nd Sparse cells
Kcnip210 2 + + + + + Clustered
scattered
cells
Scattered cells + (IC, weak) nd nd nd + (IO, weak)
Kcnip310 2 + + + + + Clustered
scattered
cells
Sparse cells Sparse cells, DR,
LC
+ (PG, LC) Mol, Pu, Gr (+) Sparse cells
Kcnip410 2 + + + + nd Clustered
scattered
cells
Sparse cells Scattered cells,
DTN
+ (LC and Sparse
cells)
Pu (+) + (PRP, DMX)
Lcp1 1 + + + + (+) Clustered
Sparse cells
Sparse cells Sparse cells Scattered cells (V,
strong)
Pu, Gr + + (VII, AMB, XII
and scattered
cells)
Letm1 2 + + + + + Clustered
Sparse cells
Sparse cells Sparse cells Scattered cells Pu, Gr + Scattered cells
Lpcat2 2 + + + + + nd nd nd Sparse cells Pu + Sparse cells
Macf1 1 Ub + + + + + Ubiquitous Ubiquitous Ubiquitous Ubiquitous Pu, Gr + Ubiquitous
Mcc11 1 nd nd nd nd nd nd nd nd nd Pu, Gr nd nd
Mcfd2 1 + + + + + Clustered
sparse cells
Scattered cells Sparse cells Sparse cells Pu, Gr + Sparse cells
Myl1 1 + + nd + + nd nd nd nd Gr + nd
Myl4 2 V nd + (+) nd + nd nd nd nd nd nd PGRN, VII, DMX
Myl6 1 Ub + + + + + Ubiquitous Ubiquitous Ubiquitous Ubiquitous Pu, Gr + Ubiquitous
Mylpf 1 + nd nd + nd nd nd nd nd Pu, Gr nd nd
Ncald 1 + + + + + + (PVT, Scattered cells + (DR strong, + (LC and scattered Gr nd Scattered cells
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MH, AD and
scattered
cells)
PBG, LC,
scattered cells)
cells)
Ncs1 1 + + + + + Clustered
scattered
cells
Sparse cells + (RN, III and
scattered cells)
Scattered cells Mol, Pu. Gr + Scattered cells
Necab112 2 V + + + + + + (PVT, RT,
RE, MV, LP)
Sparse cells Sparse cells Sparse cells Pu, Gr (+) Scattered cells
Necab213 2 V + + + + + + (PVT,
MH, LH and
scattered
cells)
Sparse cells + (DR strong and
scattered cells)
+ (PG, TRN, PSV,
PBl, SPIV)
Pu nd + (IO and
scattered cells)
Necab3 3 + + nd + + + (MH, LH
and
scattered
cells
nd + (RN, MEV and
scattered cells)
+ (V and scattered
cells)
Pu, Gr + + (VII and
scattered cells)
Nin 2 + + + + + Ubiquitous + (VMH) Sparse cells, III + (PG, TRN, V and
sparse cells)
Pu, Gr (+) Scattered cells
Nkd1 2 + nd nd + nd + (PVT, AD/
AV, PF, CM,
PCN, RE)
+ (SCH) Sparse cells nd Pu, Gr (+) Sparse cells
Nkd2 2 V nd nd nd + nd nd VMH sc, PH,
ARH, PVT
(faint)
SC scattered cells nd nd nd nd
Nucb1 2 + + + + + nd Sparse cells Sparse cells, LC + (V and scattered
cells)
Pu + + (VII and
scattered cells)
Nucb2 2 + + + + + + (PF and
sparse cells)
+ (LHA, PVH
and sparse
cells)
+ (EW and sparse
cells, LC, MEV
+ (LC and sparse
cells)
nd nd Sparse cells
P4htm 1 + + + + + Sparse cells Scattered cells Sparse cells Scattered cells Pu, Gr + Scattered cells
Pdcd6 1 + + + + + Sparse cells nd + (RN) + (V, PRN, PG,
TRN)
Pu + + (VII)
Pef1 1 + + + + nd Sparse cells,
PF, AD
Scattered cells Sparse cells + (V and sparse
cells)
Pu + NTS, DMX, XII
and scattered
cells)
Pkd2 1 nd nd nd + nd nd nd nd nd Pu nd nd
Plcg1 1 + + + + + Clustered
sparse cells,
AD
Scattered cells Sparse cells Scattered cells Pu, Gr + Scattered cells
Plch1 1 nd nd nd nd nd + (RT, LH,
weak)
+ (STN,
weak)
Sparse cells, CUN nd nd nd Sparse cells
Plch214 1 + + + + + + (PVT, LH
and
scattered
cells)
+ (SCH) Sparse cells Sparse cells Gr + Scattered cells
Plcz1 2 + + nd nd + nd nd nd nd nd + nd
Pls3 2 nd + nd + + + (AD, LD,
PF, MH,
VPN)
Sparse cells + (RN, III, MEV
and sparse cells)
+ (PG, TRN, V and
sparse cells)
Pu nd + (VII, IO, XII,
DMX and
scattered cells)
Ppp2r3c 1 + + + + + Sparse cells nd Sparse cells Scattered cells Pu, Gr + Scattered cells
Ppp2r3d 1 + + + + + Scattered Scattered cells Scattered cells Scattered cells Pu, Gr + Scattered cells
(continued on next page)
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Gene name ISH
Nr
Marker Telencehalon Diencephalon Mesencephalon Metencephalon Myelencephalon
OB CTX BG HPF AMY Thalamus
(TH)
Hypothalamus
(HY)
Midbrain (MB) Pons (P) Cerebellum
(CBX)
DCN Medulla
oblongata (MY)
cells (weak) (weak) (weak) (weak) (weak)
Ppp3r1 3 Ub + + + + + Ubiquitous Ubiquitous Ubiquitous, DR,
LC
Ubiquitous Pu, Gr + Ubiquitous
Prkcsh 3 + + + + + Scattered
cells (weak)
Scattered cells
(weak)
Scattered cells
(weak), DR, LC
Scattered cells
(weak)
Pu, Gr + Scattered cells
(weak)
Pvalb 22 + + + + + + (RT and
sparse cells)
+ (PV1, STN,
MM and
sparse cells)
+ (RN, III, MEV
ND and more)
+ (PG, NLL, TRN
and more)
Mol, Pu + + (PRP, VII,
LRN and more)
Rab11ﬁp3 1 Ub + + + + + Ubiquitous Ubiquitous Ubiquitous Ubiquitous Pu, Gr + Ubiquitous
Rab11ﬁp4 2 Ub + + (+) + + Ubiquitous Ubiquitous Ubiquitous Ubiquitous Pu, Gr (+) Ubiquitous
Rasgrp115 2 Ub + + + + + Ubiquitous Ubiquitous Ubiquitous Ubiquitous Pu, Gr + Ubiquitous
Rasgrp2 2 + + + nd nd Sparse cells Sparse cells Sparse cells Sparse cells nd nd Sparse cells
Rcn1 2 + + + nd + + (PVT,
MH)
+ (LHA and
Scattered
cells)
Sparse cells, DR,
EW
nd nd nd Sparse cells
Rcn2 2 Ub + + + + + + (MH, AD,
PVT, PF)
Ubiquitous Ubiquitous (DR
strong)
Ubiquitous (LC
strong)
Pu, Gr + Ubiquitous
Rcvrn 1 + + + + nd nd nd nd nd Pu, Gr (railroad
track)
(+) nd
Reps1 1 + + + + + Scattered
cells
Scattered cells Scattered cells Scattered cells Pu, Gr + Scattered cells
Reps2 2 + + + + + Ubiquitous Scattered cells Ubiquitous, III, DK Ubiquitous Mol, Pu, Gr (sp) ++ Ubiquitous
Rhbdl3 1 + + + + + Scattered
cells
Scattered cells Scattered cells Scattered cells Pu, Gr (railroad
track, puﬀs)
Scattered cells
Rhot1 1 + + + + + nd nd Sparse cells Sparse cells Pu, Gr (+) Sparse cells
Rhot2 2 + + + + + Scattered
cells
Scattered cells Scattered cells Scattered cells Pu, Gr + Scattered cells
Ryr116 2 + + + + + nd nd nd nd Pu + Scattered cells
Ryr217 1 Ub + + + + + + (RT, LH) Ubiquitous Ubiquitous Ubiquitous Pu, Gr (railroad
track
+ Ubiquitous
S100a9 1 + nd nd nd nd nd nd nd nd nd nd nd
S100a10 2 + + + sp,
SI,
NDB,
Cla
+
MS,
LS
+ + (AD) + (PVH
strong)
+ (RN, III, MEV,
DR, SNc & VTA
strong), CSm, V)
+ (TRN, CS, V,
LDT, SLD, LC
strong, VII, MARN,
LAV, IO)
Pu, rare cells in
Gr
(+) + (VII, RM,
AMB -strong-,
XII, DMX, NTS,
DMV)
S100a11 1 ? + nd + + Sparse cells Sparse cells Sparse cells Sparse cells Pu + Sparse cells
S100a1618 1 + + + + (+) Ubiquitous
(weak) glia ?
Ubiquitous
(weak) glia
Ubiquitous (weak) Ubiquitous (weak) Pu, Gr, Wm + Ubiquitous
(weak)
S100b19 + + + + + Scattered
cells
Scattered cells Ubiquitous (RN,
ME, III strong)
Ubiquitous (V
strong)
Mol, Pu, Gr,
Wm
+ Ubiquitous (VII,
AMB, XII strong)
Scgn20 1 + + nd + (+) nd nd nd nd Pu nd DMX, LC (?),
sparse cells
Sdf4 1 + + + + + Sparse cells Scattered cells Scattered cells Ubiquitous (weak) Pu, Gr + Ubiquitous
(weak)
Slc25a12 1 Ub + + + + + Ubiquitous Ubiquitous Ubiquitous Ubiquitous (strong) Pu, Gr ++ Ubiquitous
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(strong)
Slc25a23 1 Ub + + + + + Ubiquitous Ubiquitous Ubiquitous Ubiquitous Pu, Gr + Ubiquitous
Slc25a25 2 + + + + (+) + (AD and
Sparse cells)
Sparse cells + (RN, MEV, III,
IV and more)
patchy
+ (PG, TRN, V and
more)
Pu nd + (VI, VII, XII
and more)
Smoc1 2 + nd nd nd + + (PVT and
AD weak,
MH strong)
nd nd + (LC weak) nd nd nd
Smoc2 2 nd nd nd + + nd nd nd Nd nd nd nd
Sparc 4 Ub + + + + + Ubiquitous Ubiquitous Ubiquitous Ubiquitous Mol, Pu, Gr, pia
mater
+ Ubiquitous
Sparcl1 2 ub + + + + + Ubiquitous Ubiquitous Ubiquitous Ubiquitous Mol
(basket cells?),
Pu, Gr
++ Ubiquitous
Spna2 1 Ub + + + + + Ubiquitous Ubiquitous Ubiquitous Ubiquitous Pu, Gr + Ubiquitous
Spock1 2 + + + + + Ubiquitous
(PVT, PT,
RE, AD, RT)
Scattered cells Scattered cells Ubiquitous (PG,
TRN, V, PSV strong)
Mol, Pu, Gr
(Golgi cells?)
+ Ubiquitous (VII,
XII, AMB, PGRN
strong)
Spock2 2 Ub + + + + (+) Ubiquitous Ubiquitous Ubiquitous Ubiquitous Mol, Pu, Gr + Ubiquitous
Spock3 2 + + + + (+) + (PVT, RE,
LD, RT)
Ubiquitous
Scattered cells Scattered cells
(DR strong, III)
+ (V, CSm, LC) Mol, Pu, Gr + + (VI, VII, AMB,
XII)
Sri 2 + + + + + Sparse cells Sparse cells Sparse cells Sparse cells Pu, Gr (railroad
track)
+ Sparse cells
Stim121 1 Ub + + + + + Ubiquitous Ubiquitous Ubiquitous Ubiquitous (V
strong)
Pu + Ubiquitous (VII
strong)
Stim2 2 + + + + + nd nd Sparse cells
(weak)
Sparse cells (weak) Pu, Gr + Sparse cells
(VII)
Tesc 2 + + + + + + (MH,
PVT, AD)
Sparse cells + (RN, MEV, SC,
III)
+ (PG, V, TRN,
NLL)
Gr + + (VI, VII, LAV,
XII, AMB)
Tnnc1 2 V nd +
CLA
Nd nd nd nd nd nd nd nd nd nd
Usp32 1 + + (+) + (+) Sparse cells
(weak)
Sparse cells
(weak)
Sparse cells
(weak)
Sparse cells Pu nd Sparse cells
Utrn 2 + + + nd (+) nd nd + (MEV) + (PG, V, TRN) Pu, Gr (+) + (VII, MV, XI,
PGRN)
Vsnl22 3 + + + + (+) + (AD, LD
and sparse
cells)
+ (ZI, STN
and scattered
cells)
Ubiquitous + (PG, TRN and
scattered cells)
Gr + Ubiquitous
Zzef1 1 nd + Nd + nd nd nd nd Sparse cells (weak) Pu (+) Sparse cells
(weak)
1500003O03Rik 1 + + + + + Scattered
cells
Sparse cells Scattered cells Scattered cells (V
strong)
Pu, Gr + Scattered cells
(VII, LRN, AMB
strong)
4732418C07Rik 1 + + + + + Scattered
cells
Scattered cells Scattered cells Scattered cells Pu, Gr, Wm + Scattered cells
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E. coli were aﬃnity puriﬁed through their GST-tag, which
was later removed by thrombin cleavage. Puriﬁed
proteins were checked by gel electrophoresis and used
for immunizing rabbits (Eurogentec, Seraing, Belgium).
The speciﬁcity of the obtained antibodies was tested by
immunoblotting. The diluted, straight antisera were used
for immunohistochemistry.
Immunoblotting
Extracts of mouse brains were subjected to 12% sodium
dodecyl sulfate (SDS)-gel-electrophoresis (50-lg protein
loaded per lane) followed by transfer on nitrocellulose
paper and immunoblot using the antisera against
Hpcal44 and Tesc diluted 1:2000. The bound antibody
was revealed with an HRP-labeled secondary antibody
and the reaction ampliﬁed by chemiluminescence.
RESULTS
Identiﬁcation of genes of the EF-hand super-family in
the mouse genome
Previous studies on the proteins of the EF-hand super-
family of Ca2+-binding proteins have revealed an extreme
diversity in their structure, functional activities and cellular
localization (extracellular, membrane-bound, cytosolic,
cytoskeleton-associated, in Golgi compartments, in other
vesicles, in the nucleus and more) (Kawasaki et al., 1998;
Persechini et al., 1989; Moncrief et al., 1990; Lewit-
Bentley and Rety, 2000; Haiech et al., 2004; Schwaller,
2009, 2010; Yanez et al., 2012). Through extensive
examination of the Uniprot and NCBI Gene databases
(see Experimental procedures, Section ‘‘Bioinformatics’’),
we found that this family comprises in mouse at least 249
putative members. According to Gene Ontology
terms, we have classiﬁed these proteins into several cate-
gories: Ca2+ sensors/buﬀers, enzymes, cytoskeleton
organization/dynamics (actin ﬁlament binding/assembly,
microtubule dynamics, motor proteins, muscle cell struc-
ture/homeostasis), transporters, extracellular matrix
organization/dynamics, ion channels (Ca2+, K+), mod-
ulators of ion channels, guanyl-nucleotide exchange fac-
tors and more (alphabetical list in Table 1).
Gene expression pattern atlas of the EF-hand family
genes in the mouse brain
For each gene encoding an EF-hand domain containing
protein, the ABA database of ISH data was consulted,
and the diﬀerent images available (mostly sagittal, but
Fig. 1. Schematic brain representation showing speciﬁc expression of EF-hand genes in discrete areas, Part 1. A schematic view of a brain sagittal
section, highlighting the diﬀerent areas analyzed in this study. For each area, the genes which are preferentially expressed in this region are listed.
For details, see Tables 2–7. Abbreviations: MOB: main olfactory bulb; CTX: cerebral cortex; HPF: hippocampal formation; so: stratum oriens; STR:
striatum; HY: hypothalamus; TH: thalamus; VL: lateral ventricle; MB: midbrain; P: pons; MY: medulla; CBX: cerebellum. All other abbreviations are
detailed in the list of abbreviations. Drawing is adapted from Dong (2008).
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also coronal, see Table 2, column 2) were analyzed in
detail focusing on diﬀerent brain areas: main olfactory
bulb (OB), accessory olfactory nucleus (AON), cerebral
cortex (CTX), basal ganglia (BG), hippocampus (HPF),
amygdala (AMY), thalamus (TH), hypothalamus (HY),
midbrain (MB), cerebellum (CBX), pons (P), medulla
(MY), and in clearly identiﬁable substructures within
each areas. Of the 249 genes forming the EF-hand
super-family, ABA data were available for 222 genes,
among which 135 showed a detectable expression
pattern in the brain. For 87 genes (‘‘n.e.d’’ in Table 1),
no discernible signals were observed with respect to
brain expression. For the remaining 27 genes (‘‘n.d’’ in
Table 1), no expression data were available in the ABA.
The results for the 135 genes clearly expressed in the
brain are presented in Table 2, and schematized in
Figs. 1 and 2. Tables 3–7 summarize expression details
in the OB/AON, the cerebral cortex (barrel ﬁeld of the
primary somatosensory area), the basal ganglia, the
hippocampal formation and the amygdala, respectively.
Figs. 3–5 show examples of genes expressed in the
cerebral cortex, the hippocampus and the cerebellum,
respectively. Most of the EF-CaBP-encoding genes are
expressed concomitantly in diﬀerent brain areas;
nevertheless some genes show detectable expression
in unique, or at least a limited number of brain
structures (Table 2). These include Cabp1 (weak
expression in CTX and PIR, in HPF CA3 sp, and few
sparse cells in MY); Cblb (weak expression in all layers
of CTX, strong expression in dentate gyrus, granule cell
layer (DG sg) and CA3 sp); Cbl (weak expression in DG
sg and CA1-3 sp); Cetn3 (sparse cells in CA1-3 sp and
DG sg); Dgka (sparse cells in CA3 sp and DG sg);
Efcab1 (weak expression in CTX and HPF); Efcab12
(weak expression in CBX and HPF); Ehd1 (sparse cells
in CA1-3 sp and strong expression in DG sg); Gca
(CTX all layers, CA1 sp); Mcc (CBX Pu); Myl4 (CTX
layers 5/6, lateral amygdalar nucleus); Nkd3 (CA3 sp);
Pkd2 (sparse cells in CA1-3 sp and DG sg); Plch1
(weak expression in TH and MY; S100a9 (weak
expression in OB); Tnnc1 (expressed in diﬀerent CTX
layers – 2/3, 4, 6 – depending on the area).
Expression patterns of the EF-hand family genes in
the olfactory bulb
Most of the EF-hand family genes appear to be expressed
in the main olfactory bulb: 111 out of the 135 genes
expressed in brain are present with detectable
expression levels in the diﬀerent layers (Table 3). Most
of these genes are expressed in more than one layer,
and very few genes occur speciﬁcally in only one layer
in the OB. These include Calb1, Calu, Kcnip4, Rcn1 and
Vsnl1 for the glomerular layer; Pvalb for the outer
plexiform layer; Calm3, Cib2 and Nucb1 for the mitral
layer; Fstl1, Kcnip1, Nucb2, Rasgrp2 and Tesc for
the granular layer. Two genes encoding proteins with
Ca2+-buﬀering activity (S100A10 and S100A16)
highlight the rostral migratory stream, which conveys
newborn neurons to the olfactory bulb; in addition Cib2
marks the accessory olfactory bulb speciﬁcally.
Expression patterns of the EF-hand family genes in
the cerebral cortex
112 out of the 135 genes are expressed in the cerebral
cortex. By examining expression in the barrel ﬁeld of the
Fig. 2. Schematic brain representation showing speciﬁc expression of EF-hand genes in discrete areas, Part 2. See legend to Fig. 1.
16
ht
tp
://
do
c.
re
ro
.c
h
primary somatosensory area, we notice that several
EF-CaBP-encoding genes have a rather ubiquitous
distribution, but nevertheless some genes are
expressed in speciﬁc layers (Figs. 1 and 3, and
Table 4). These include for example Cabp1 (weak
expression in sparse cells in layers 2 and 5a), Fstl4,
Gca, Efcab4a or Rcn1 (weak expression in sparse cells
in layers 2 and 3), Myl4 (weak to moderate expression
in layers 5 and 6), S100a10 (weak expression in layer
4), Tnnc1 (expressed in diﬀerent CTX layers [2/3, 4, 6],
depending on the area).
Expression pattern of the EF-hand family genes in the
basal ganglia
Compared to the striatum, the globus pallidus expresses
less often EF-hand genes. The ventral pallidum is
highlighted speciﬁcally by Myl4. Ehd3, Reps2 and Vsnl1
are expressed only in the external globus pallidus
(GPE), whereas Dgkb and S100A11 expressing cells
are concentrated in the internal globus pallidus (GPI)
(Table 5). In a number of cases, the gene expression-
pattern replicated the subdivision of the striatum in
striosome-matrix compartments.
Fig. 3. Gene expression patterns in the cerebral cortex. ISH images for eight genes, listed in alphabetical order, and presenting a characteristic
expression pattern in the cerebral cortex (barrel ﬁeld of the primary somatosensory area), were taken from the ABA database. All images
correspond to sagittal sections. Gene expression levels range from weak (blue/green), moderate (yellow) to strong (red). The diﬀerent layers are
highlighted. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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Expression patterns in the hippocampus
The three ‘‘classical’’ EF-hand proteins Calb-D28K,
CalR and Parv have been extensively used as markers
to deﬁne discrete populations of neurons in the
hippocampus, in conjunction with immunostaining for
neurotransmitters/neuropeptides (see for example Jinno
and Kosaka, 2002). Examining the ABA database, most
of the EF-hand genes appear to be expressed in the
hippocampus: 126 out of the 135 expressed in the brain,
Fig. 4. Gene expression patterns in the hippocampus. The upper left panel is a schematic, coronal, view of the hippocampal formation.
Abbreviations: CA1/2/3: hippocampal ﬁelds; so: stratum oriens; sp: stratum pyramidale; sr: stratum radiatum; slm: stratum lacosum moleculare; DG:
dentate gyrus; sg: granule cell layer; po: polymorph layer; hf: hippocampal ﬁssure. ISH images for 17 genes, listed in alphabetical order, and
presenting a characteristic expression pattern in the hippocampus, were taken from the ABA database. All are coronal sections. Gene expression
levels range from weak (blue/green), moderate (yellow) to strong (red). Notice that stratum oriens interneurons are visible for Ncald, Capns1 or
Spock1. Some are clearly negative in the granular layer of the DG (Fstl5, Gca, Nkd2, S100b). Arrows highlight the CA1, CA2 or CA3 boundaries.
(For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
18
ht
tp
://
do
c.
re
ro
.c
h
present a detectable HPF expression. Most of them are
distributed ubiquitously according to the known sub-
divisions (CA1/2/3 (Ammon’s horn regions 1/2/3), DG
(dentate gyrus)), but some reveal an interesting par-
cellation (Table 6 and Fig. 4). Indeed, few genes are
expressed in unique areas in the CA ﬁelds, and thus could
serve as speciﬁc markers: CA1 (Calb1, Efcab12, Gca);
CA2 (Necab2, S100b); CA3 (Cabp1, Cblb, Cgref1,
Dgka, Fstl5, Ncald, Necab3, Nkd2, Smoc2). Most of these
genes show detectable expression in the DG at diﬀerent
levels (only eight are clearly negative in DG: Cabp1,
Cgref1, Efha2, Fstl5, Gca, Mylpf, Nkd2, Tnnc2), and we
found none that was expressed only in DG and not in
the CA ﬁelds.
An additional focus was given to possible expression
in nerve cells of the stratum oriens, which are
exclusively short axon cells (interneurons). A signiﬁcant
proportion of Parv-immunoreactive neurons are found in
the stratum oriens of the CA1 and CA3 regions, and a
few are located in the radiatum layer (Celio, 1990). As
listed in Table 6 , 51 EF-CaBP-encoding genes show
expression in the stratum oriens, and thus could partly
be co-expressed with Pvalb. Most of these are ubiqui-
tously expressed genes and therefore of minor anatomi-
cal relevance as speciﬁc markers, but 17 (Calb1, Calb2,
Capns1, Dtna, Eps15, Ncald, Ncs1, Necab1, Necab2,
Plch2, Pvalb, Reps 1, Ryrt, Sparc, Spock1, Spock3,
Vsnl1) are selectively expressed in scattered neurons
and could help subdivide the interneuronal population in
additional subclasses. Particularly interesting in this con-
text are Sparc, Spock1 and Spock3, which are also
expressed in the periglomerular cells of the OB, the RT
and the molecular layer of the cerebellum.
Two experimental approaches, ISH and
immunostaining, were performed in order to analyze,
respectively at the gene and protein level, the
co-expression in the hippocampus of Pvalb/Parv, with
either Ncald (neurocalcin-d), Hpcal4 (hippocalcin-like4) or
Pls3 (plastin3). Ncald is mainly expressed in the granule
layer of the DG, and in the pyramidal layer of the CA3
region. In addition, sparse cells are present in the hilus of
the DG, in the stratum oriens, stratum radiatum and
stratum lacunosum moleculare, and isolated cells can be
found also in the pyramidal layer of the CA1 region
(Fig. 4). Only a subset of Pvalb expressing cells also
expressed Ncald in the CA1 region, both in the pyramidal
layer of the hippocampus (sp) and stratum oriens.
(Fig. 6C, D). Pls3 is strongly expressed in the pyramidal
layer of the CA1-2-3 regions (Fig. 6E, J). No clear
expression is visible in the stratum oriens. In addition,
isolated cells are present in the DG and in the hilus
(Fig. 6H). Co-localization of Pls3 with Pvalb mRNA is
observed in the pyramidal layer of CA1/3 regions, in the
stratum lacunosum moleculare and in the granular layer
of the DG (Fig. 6H–K). For Hpcal4, we found no evidence
for co-expression with Pvalb (not shown). Similar co-
expression experiments by ISH were performed with
Eps15 and Sparcl1, and the results highlighted the co-
expression of these two genes in virtually all Pvalb
expressing neurons in the HPF (data not shown).
Immunostaining experiments using anti-Ncald,
respectively -Hpcal4, combined with anti-Parv, have
conﬁrmed these results. Indeed, Ncald-immunoreactive
neurons in the CA1 region (in stratum oriens and sp)
represent a subset of Parv-immunoreactive ones.
Nevertheless, some neuronal populations stained
positive for Parv but negative for Ncald, while in others
it was the other way round (Fig. 7A, B). The same was
true for the CA3 region (not shown). For Hpcal4, we
found no evidence for co-expression in Parv-positive
neurons in the hippocampus in the CA sp and stratum
oriens (Fig. 7C–E).
Fig. 5. Gene expression patterns in the cerebellum. The upper left panel shows the Nissl staining of a coronal section, highlighting the Purkinke-
(Pu), the molecular- (Mo) and the granular (Gr) layers. The other seven pictures, taken from the ABA database, show the ISH images for seven
genes, listed in alphabetical order, presenting a characteristic expression pattern. All are coronal sections, except Sdf4 (sagittal). Gene expression
levels range from weak (blue/green), moderate (yellow) to strong (red). Some genes are strongly expressed in the Pu layer (Dgkg, Eps15, Pls3,
Ryr1), with little or no staining in other layers. Inversely, some are expressed in the Gr layer (Sdf4, Tesc), with eventually few cells stained in the Pu
layer. Only few genes (see list Table 2) show expression in the Mo layer (an example is given here with S100b). Note the presence of a ‘‘railroad
track’’ of parallel cells expressing the Sdf4-gene. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web
version of this article.)
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Table 3. EF-hand family genes expressed in the main olfactory bulb and accessory olfactory nucleus. List of the EF-hand genes showing a detectable
expression in the main olfactory bulb (OB), and the accessory olfactory nucleus (AON), according to the ISH images of the ABA database. ++
corresponds to moderate/strong expression, and + to low expression. Abbreviations: AOB: accessory olfactory bulb; END: endopiriform nucleus; CLA:
Claustrum; RMS: rostral migratory stream; gl: glomerular layer; gr: granular layer; mi: mitral layer; opl: outer plexiform layer
Gene gl opl mi gr AON Gene gl opl mi gr AON
Actn1 + + + + Necab1 + + Sparse cells
Actn3 + + + + Necab2 + + Sparse cells
Actn4 + + + Necab3 ++ ++ +
Cabp1 + + Nin + + ++ ++ +
Cabp4 + + + + Nkd1 + + Sparse cells
Cabp5 + + + Nucb1 +
Calb1 + Sparse cells Nucb2 + +
Calb2 ++ ++ ++ ++ ++ P4htm + + +
Calm1 ++ ++ ++ ++ Pdcd6 + Sparse cells
Calm2 ++ ++ ++ ++ Pef1 + ++ +
Calm3 + + Plcg1 ++ ++ + +
Calu + Plch2 + + ++ ++ ++
Capn2 + ++ + Sparse cells Pls3 ++ END, CLA
Capn3 ++ ++ + Sparse cells Ppp2r3c + + + Sparse cells
Capn10 + + + Sparse cells Ppp2r3d + + + + +
Capns1 ++ + ++ + ++ Ppp3r1 ++ + ++ ++ ++
Cbara1 ++ + ++ + ++ Prkcsh + + + + +
Cetn2 + + + + Pvalb ++ Sparse cells
Cgref1 ++ Rab11ﬁp3 ++ ++ ++ ++ ++
Cib2 + AOB +++ Rab11ﬁp4 ++ ++ ++ ++ ++
Dgkb + ++ ++ Rasgrp1 ++ + ++ + +
Dgkg + ++ + ++ Rasgrp2 +
Drp2 + + ++ ++ Rcn1 +
Dtna + + ++ + ++ Rcn2 ++ + ++ + +
Dtnb + + + Rcvrn + + + +
Efcab4a + + Reps1 ++ + ++ + +
Efhb + + + Reps2 + + + + ++
Efhd2 ++ + ++ + ++ Rhbdl3 ++ ++ ++
Ehd2 + + + + Rhot1 + + + Sparse cells
Ehd3 ++ ++ + Rhot2 ++ ++ ++ ++
Eps15 + + ++ + + Ryr1 ++ + ++
Eps15l1 + + + + Ryr2 ++ + ++ ++ ++
Fkbp9 + + Sparse cells S100a9 + + +
Fkbp10 + + S100a10 + + RMS
Fstl1 + ++ S100a16 + + + Sparse cells, RMS
Fstl4 + + S100b + + Sparse cells
Fstl5 ++ ++ Scgn ++ ++ ++
Gpd2 + + + Sdf4 ++ ++ + Sparse cells
Guca1b ++ + + + Slc25a12 ++ + ++ ++ ++
Hpca + + ++ Slc25a23 ++ + ++ ++ +
Hpcal1 + + Sparse cells Slc25a25 + + + +
Hpcal4 + ++ ++ Smoc1 + +
Itsn1 + + ++ + Sparc ++ + + + Sparse cells
Itsn2 + + Sparcl1 ++ ++ ++ ++ ++
Kcnip1 + Sparse cells Spna2 ++ + ++ + ++
Kcnip2 ++ ++ + Spock1 ++ + ++ + ++
Kcnip3 + ++ + ++ Spock2 ++ + ++ + ++
Kcnip4 + Sparse cells Spock3 + + + Sparse cells
Lcp1 ++ ++ ++ + Sri + + + +
Letm1 + ++ Sparse cells Stim1 + + + +
Lpcat2 + + Sparse cells Stim2 + + + +
Macf1 ++ + ++ + + Tesc + +
Mcfd2 + + + Usp32 + ++ Sparse cells
Myl1 + + + Utrn + + + +
Myl6 ++ + ++ + ++ Vsnl1 + +
Mylpf + ++ + 1500003O03Rik + ++ + +
Ncald + + + + ++ 4732418C07Rik + ++ + Sparse cells
Ncs1 + ++ + +
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Table 4. EF-hand family genes expressed in the cerebral cortex. The table lists the expression of the 135 Ef-hand family genes in the six layers of the
somatosensory isocortex, at the level of the barrel cortex. The analysis was based on both sagittal and coronal ISH images of the ABA. Legends: nd:
not detected; spa.+/: few isolated cells, weakly stained; spa.+, spa.++, spa.+++: sparse cells, weakly/moderately/strongly stained; ub.+,
ub.++, ub.+++: ubiquitous weak/moderate/strong staining; SM: somatomotor cortex; SS: somatosensory cortex; VIS: visual cortex
Gene name Layer 1 Layer 2 Layer 3 Layer 4 Layer 5a Layer 5b Layer 6
Actn1 nd Ub.+++ Ub.++ Spa.+ Spa.+ Spa.+ Ub.++
Actn3 nd Spa.+ Spa.+ Spa.+/ Spa.+ Spa.+ Spa.+
Actn4 nd Spa.+ Spa.+ Spa.+/ Spa.+ Spa.+ Spa.+
Cabp1 nd Spa.+ nd nd Spa.+ nd nd
Calb1 Spa.+/ Ub.+++ Ub.+++ Ub.+ Spa.++ Spa.++ Spa.++
Calb2 nd Spa.+ Spa.+ Spa.+ Spa.+ Spa.+ Spa.+
Calm1 nd Ub.++ Ub.++ Spa.+ Ub.++ Ub.++ Ub.++
Calm2 Spa.+ Ub.+++ Ub.+++ Ub.++ Ub.+++ Ub.+++ Ub.+++
Calm3 nd Spa.+ Spa.+ nd Spa.+ Spa.+ Spa.+
Capn2 nd Spa.+/ Spa.+ Spa.+ Spa.+/ Spa.++ Spa.+
Capn3 Spa.+ Ub.+ Ub.+ nd Spa.+ Spa.+ nd
Capn8 nd Spa.+ Spa.+ nd Spa.+ Spa.+ Spa.+
Capns1 nd Spa.+ Spa.+ nd Spa.++ Spa.++ Spa.+
Cbara1 nd Ub.+ Ub.+ Ub.+ Ub.+ Ub.+ Ub.+
Cblb nd Spa.+ Spa.+ Spa.+/ Spa.+ Spa.+ nd
Cetn2 nd Spa.+ Spa.+ nd Spa.+ Spa.+ Spa.+
Cib2 nd Spa.+ Spa.+ nd Spa.+/ Spa.+/ Spa.+/
Dgkb nd Ub.++ Ub.+ nd Spa.+ Spa.+ Spa.+
Dgkg nd Spa.+ Spa.+ nd Spa.+ Spa.+ Spa.+
Drp2 nd Ub.++ Ub.++ Ub.++ Ub.++ Ub.++ Ub.+
Dtna Spa.+ Ub.+ Ub.+ Spa.+ Ub.+ Ub.+ Ub.+
Dtnb nd Spa.+ Spa.+ nd Ub.+ Ub.+ Ub.+
Efcab4a nd Spa.+ Spa.+ nd nd nd nd
Efha2 nd Spa.+/ nd nd Spa.+/ Spa.+/ nd
Efhb nd Spa.+/ Spa.+/ nd Spa.+/ nd nd
Efhd2 Spa.+ Ub.+++ Ub.++ Spa.+ Ub.++ Ub.++ Ub.++
Ehd1 nd Spa.+/ Spa.+/ nd Spa.+/ Spa.+/ Spa.+/
Ehd2 Ub.++ Ub.+++ Ub.+++ Ub.++ Ub.++ Ub.++ Ub.++
Ehd3 Spa.+ nd nd nd Spa.++ Spa.++ Spa.+/
Eps15 Ub.++ Ub.++ Ub.++ Ub.++ Ub.++ Ub.++ Ub.++
Eps15l1 nd nd nd nd Spa.+/ Spa.+/ Spa.+/
Fkbp9 nd Ub.++ Ub.++ Spa.+ Ub.+ Ub.+ Ub.+
Fkbp10 nd Spa.+ Spa.+ nd Spa.+ Spa.+ nd
Fstl1 nd Spa.+ Spa.+ nd Spa.+ Spa.+ Spa.+
Fstl4 nd Spa.+ Spa.+ nd nd nd nd
Gca nd Spa.+/ Spa.+/ nd nd nd nd
Gpd2 nd Ub.+ Ub.+ Spa.+ Ub.+ Ub.+ Ub.+
Guca1b Spa.++ Ub.++ Ub.+ Spa.+ Ub.+ Ub.+ Ub.+
Hpca Spa.+ Ub.++ Ub.++ Ub.+ Spa.++ Spa.++ Ub.++
Hpcal4 Spa.+ Ub.+++ Ub.++ Spa.+/ Spa.++ Spa.+ Ub.+++
Itsn1 nd Spa.+ Spa.+ Spa.+ Ub.+ Ub.+ Ub.+
Kcnip1 nd Spa.+ Spa.+ nd Spa.+/ Spa.+/ Spa.+/
Kcnip2 nd Ub.+ Ub.+ Ub.+ Spa.++ Spa.++ Ub.+
Kcnip3 nd Ub.+ Ub.+ Ub.+ Ub.+++ Ub.+++ Ub.++
Kcnip4 nd Spa.+/ nd nd Spa.+/ Spa.+/ Spa.+/
Lcp1 Spa.+ Spa.+ Spa.+ nd Spa.+ Spa.+ Spa.+
Letm1 nd Ub.+ Ub.+ Ub.+ Ub.+ Ub.+ Ub.+
Lpcat2 nd Spa.+/ Spa.+/ nd nd nd Spa.+/
Macf1 Spa.+ Ub.+ Ub.+ Ub.+ Ub.+ Ub.+ Ub.+
Mcfd2 nd Spa.+ Spa.+/ nd Spa.+ Spa.+ Spa.+
Myl1 Spa.+ Spa.+ Spa.+ Spa.+ Ub.+ Ub.+ Ub.+
Myl4 nd nd nd nd Spa.++ Spa.++ Ub.+
Myl6 nd Ub.++ Ub.++ Ub.++ Ub.+++ Ub.+++ Ub.+++
Ncald Spa.+++ Ub.+++ Ub.++ Spa.+ Ub.+++ Spa.+++ Ub.+++
Ncs1 Spa.+++ Ub.+ Ub.+ Spa.+ Ub.++ Ub.++ Ub.+
Necab1 Spa.+ Spa.+++ nd nd Spa.++ Spa.+ Spa.+
Necab2 Spa.+ Spa.+ nd nd nd nd Spa.+/
Necab3 nd Ub.+ Ub.+ nd nd nd Ub.+
Nin nd Ub.+ Ub.+ Spa.+ Spa.+ Spa.+ Ub.+
Nucb1 nd Spa.+ nd nd Spa.+ Spa.+ Spa.+/
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Expression pattern of the EF-hand family genes in the
amygdala
The most speciﬁc marker for an amygdalar subnucleus is
Myl4, which only marks the lateral amygdala nucleus, part
of basomedial amygdalar nucleus and endopriform
nucleus. Rcn1 is positive in the cortical amygdalar area,
posterior part medial zone (layer 2), Rhot2 in basolateral
amygdalar nucleus; Smoc1 in CoAPm layers 2 + 3 and
posterior amygdalar nucleus and Smoc2 in posterior
amygdalar nucleus (Table 7).
Expression patterns of the EF-hand family genes in
the cerebellum
Calb-D28K and CalR are useful markers for neuronal
populations in the cerebellum, being speciﬁc for Purkinje
Table 4 (continued)
Gene name Layer 1 Layer 2 Layer 3 Layer 4 Layer 5a Layer 5b Layer 6
Nucb2 nd Ub.+ Spa.+/ nd Spa.+ Spa.+ Ub.+
P4htm nd Spa.+ Spa.+ nd Spa.+ Spa.+ Spa.+
Pdcd6 nd Spa.+ Spa.+ nd Spa.+ Spa.+ nd
Pef1 Spa.+ Ub.+ Ub.+ Spa.+ Spa.+ Spa.+ Spa.+
Plcg1 Spa.+ Spa.+ Spa.+ Spa.+ Spa.+ Spa.+ Spa.+
Plch2 Spa.+ Ub.+ Ub.+ Ub.+ Spa.+ Spa.+ Spa.+
Pls3 nd Spa.+ nd nd Spa.+ Spa.+ Spa.+/
Ppp2r3c nd Ub.+ Ub.+ Spa.+/ Spa.+ Spa.+ Spa.+
Ppp2r3d nd Ub.+ Ub.+ Ub.+ Ub.+ Ub.+ Ub.+
Ppp3r1 Spa.+ Ub.+++ Ub.+++ Ub.+ Ub.++ Ub.++ Ub.++
Prkcsh nd Ub.+ Ub.+ nd Ub.+ Ub.+ Ub.+
Pvalb nd Spa.+++ Spa.+++ Spa.+++ Spa.+++ Spa.+++ Spa.+++
Rab11ﬁp3 Spa.+ Ub.+++ Ub.+++ Ub.+++ Ub.+++ Ub.+++ Ub.+++
Rab11ﬁp4 Spa.+ Ub.++ Ub.++ Spa.+ Ub.++ Ub.++ Ub.++
Rasgrp1 Spa.+ Ub.+++ Ub.+++ Ub.+ Ub.+ Ub.+ Ub.++
Rasgrp2 nd nd nd nd Spa.+ Spa.+ nd
Rcn1 nd Spa.+ Spa.+ nd nd nd nd
Rcn2 Spa.+ Spa.+ Spa.+ Spa.+/ Ub.++ Ub.++ Spa.+
Rcvrn nd Spa.+ Spa.+ nd Spa.+/ Spa.+/ nd
Reps1 nd Spa.+ Spa.+ nd Spa.+ Spa.+ Spa.+
Reps2 Spa.++ Ub.++ Ub.++ Ub.++ Ub.++ Ub.++ Ub.++
Rhbdl3 nd Ub.+ Ub.+ Ub.+ Ub.+ Ub.+ Spa.+
Rhot1 Spa.+ Ub.+ Ub.+ Ub.+ Ub.+ Ub.+ Ub.+
Rhot2 Spa.+ Ub.++ Ub.+ Ub.+ Ub.++ Ub.++ Ub.+
Ryr1 nd Spa.+ Spa.+ nd Spa.+ Spa.+ Spa.+
Ryr2 Spa.++ Ub.+++ Ub.+++ Ub.++ Ub.++ Ub.++ Ub.++
S100a10 nd nd nd Spa.+ nd nd nd
S100a11 nd Spa.+/ Spa.+/ nd Spa.+/ nd nd
S100a16 nd nd nd nd Spa.+ Spa.+ Spa.+
S100b nd nd nd Ub.++ Ub.++ Ub.++ Spa.++
Scgn nd Spa.+ Spa.+ nd nd nd Spa.+/
Sdf4 Spa.+ Ub.++ Ub.+ nd Spa.+ Spa.+ Spa.+
Slc25a12 Spa.+ Ub.+ Ub.+ Spa.+ Ub.++ Ub.++ Ub.+
Slc25a23 Spa.+ Ub.+++ Ub.++ Ub.+ Ub.++ Ub.++ Ub.+
Slc25a25 nd Spa.+ Spa.+ nd Spa.+ Spa.+ Spa.+
Sparc Spa.+ Spa.+ Spa.+ Spa.+ Spa.+ Spa.+ Spa.+
Sparcl1 Ub.+++ Ub.+++ Ub.+++ Spa.+++ Ub.+++ Ub.+++ Ub.+++
Spna2 Spa.+ Ub.+++ Ub.++ Ub.+ Ub.++ Ub.++ Ub.+
Spock1 Spa.+ Ub.++ Ub.++ Ub.++ Ub.++ Ub.++ Ub.+
Spock2 Ub.+++ Ub.+++ Ub.++ Ub.++ Ub.+++ Ub.+++ Ub.+++
Spock3 Spa.+ Spa.++ Spa.+ Sp+/ Ub.++ Spa.+ Spa.+
Sri nd Spa.+ Spa.+ nd nd Spa.+ Spa.+
Stim1 Spa.+ Ub.+ Ub.+ Spa.+/ Ub.+ Ub.+ Ub.++
Stim2 Spa.+/ Ub.+++ Ub.++ Spa.+/ Spa.+/ Spa.+/ Ub.++
Tesc nd Ub.+ nd nd Spa.+/ nd Spa.+
Tnnc1 nd VIS(4),
SS(2)
SM Spa.+ VIS, SS (barrel), SM nd nd Spa.+ VIS, SS, SM
Usp32 nd Spa.+ nd nd Spa.+ Spa.+ Spa.+
Utrn nd Spa.+/ nd nd Spa.+ Spa.+ Spa.+/
Vsnl1 nd Spa.+ Spa.+ nd Ub.+ Ub.+ Ub.+
Zzef1 nd nd nd nd Spa.+/ Spa.+/ nd
1500003O03Rik Spa.+ Spa.+ Spa.+ nd Spa.++ Spa.+/ Spa.+/
4732418C07Rik Spa.+ Ub.+ Ub.+ Ub.+ Ub.+ Ub.+ Ub.+
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Table 5. EF-hand family genes expressed in the basal ganglia. The table lists the 135 genes of the EF-hand family expressed in three compartments of
the basal ganglia, the striatum (S) (caudoputamen, CP), the Nucleus accumbens and the Globus pallidus. Abbreviations: GPE: Globus pallidus,
external; GPI: Globus pallidus, internal: nd: no positive elements detected; mtx: probably neurons of the matrix compartment positive; msi: medium
spiny interneurons; SI: substantia innominata; spa +/spa.++/spa.+++: sparse cells, weak/moderate/strong signal; (+) rare or few positive cells
Gene name Striatum Accumbens Globus pallidus
Actn1 + mspi +++ –
Actn3 + + +
Cabp5 + dorsal nd nd
Cabp7 (+) + (+)
Calb1 + mspi + +
Calm1 + + +
Calm2 + + +
Capn2 spa + nd +
Capn3 (+) nd nd
Capn8 + + +
Capns1 spa + + +
Cbara1 + msi + spa +
Cetn2 + + +
Cgref1 spa + spa + spa +
Cib2 + (+) +
Dgkb + mtx + GPI spa +
Dgkg + mtx + +
Drp2 + mtx + +
Dtna + + +
Dtnb + mtx + +
Efha2 nd nd +
Efhd2 spa + spa + +
Ehd1 nd nd +
Ehd2 + nd +
Ehd3 nd nd + GPE
Eps15 + mtx + +
Eps15l1 + + +
Fkbp9 + mtx + +
Fstl1 spa + spa + +
Guca1b + + +
Hpca + mtx + +
Hpcal1 spa + spa + nd
Hpcal4 + mtx + nd
Itsn1 spa + spa + +
Itsn2 nd nd (+)
Kcnip1 (+) spa (+) spa (+) spa
Kcnip2 + + nd
Kcnip3 + mtx + nd
Kcnip4 (+) spa (+) spa +
Lcp1 + + +
Letm1 + + +
Lpcat2 (+) spa (+) spa (+) spa
Macf1 + + +
Mcfd2 + + +
Myl4 nd nd Ventral pallidum
Myl6 + + +
Ncald spa +++ + spa +++
Ncs1 spa + + +
Necab1 + + nd
Necab2 + + (+)
Nin + + (+)
Nucb1 nd nd +
Nucb2 + +(>than CP) nd
P4htm spa + spa + spa +
Pdcd6 + + nd
Pef1 + + +
Plcg1 + + +
Plch2 + + (+)
Ppp2r3c spa + spa (+) +
Ppp2r3d + + +
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cells, and cells of the granular layers respectively, which
are mostly granule cells. However also unipolar brush
cells (Floris et al., 1994), the Golgi- and Lugaro cells, as
well as the monodendritic cells (Braak and Braak, 1993;
Dino et al., 1999) express CalR. Screening the ABA data-
base with a special focus on the cerebellum, 100 genes
presenting a detectable expression were found (Table 2,
and Figs. 2 and 5). The following 19 genes are speciﬁc
for the granular layer: Actn1, Cabp5, Calb2, Efcab12,
Ehd3, Fstl1, Gpd2, Guca1b, Itsn1, Kcnip3, Myl1, Ncs1,
Necab3, Plch2, Pls3, Rbhdl3, Ryr2, Sri, and Vsnl1. The
following 32 genes are speciﬁc for the Purkinje layer:
Actn3, Calb1, Calu, Capn2, Capn10, Cetn2, Dgkb,
Dgkg, Efha2, Efhb, Efhd2, Fstl4, Hpca, Hpcal1, Kcnip1,
Kcnip4, Letm1, Mcc, Mcfd2, Nucb1, P4htm, Pdcd6,
Pef1, Prkcsh, Rab11ﬁp4, Ryr1, S100a10, S100a11,
Scgn, Slc25a25, Stim1, and Zzef1. In the molecular layer
a restricted number of six genes are expressed: Pvalb
(stellate and basket cells), S100b (probably Bergmann
glia), Sparc (neuronal/glial cells), Sparcl1, Spock2,
Spock3 (Fig. 5). Expression in the Purkinje-cell layer
(Pu) does not implicitly mean expression in the
Purkinje-neuron themselves. The resolution of the ISH
does not allow for diﬀerentiating between Purkinje-
neurons and Golgi-epithelial cells, which give rise to the
Bergmann glia. One such example is Calu, which is
expressed in the Purkinje cell layer (Table 2), but found
immunohistochemically in the Golgi-epithelial cells and
Bergmann glia (Vasiljevic et al., 2012).
At least four genes (Rhbdl3, Ryr2, Sdf4, Sri) are
expressed both in the Purkinje-cell layer and in a
parallel layer of cells located at the boundary between
the granular layer and white matter (Fig. 5). No
indication of the presence of this row of cells is found in
the reference book on the cerebellum (Palay and Chan-
Palay, 1974), but in the classical studies by Golgi (1903)
and Cajal (1955) single fusiform cells located in this
boundary region are depicted.
Table 5 (continued)
Gene name Striatum Accumbens Globus pallidus
Ppp3r1 + + nd
Prkcsh + + +
Pvalb spa +++ spa +++ spa +++
Rab11ﬁp3 + + +
Rab11ﬁp4 (+) (+) (+)
Rasgrp1 + + (+)
Rasgrp2 ++ ++ nd
Rcn1 + ant + (< than S) sp ++
Rcn2 + + +
Rcvrn + ant + (> than S) nd
Reps1 spa (+) + (> than S) +
Reps2 + + + GPE
Rhbdl3 + + (+)
Rhot1 spa+ nd +
Rhot2 + + +
Ryr1 + ++ + nd
Ryr2 + + ++
S100a10 spa ++ spa ++ spa ++ (SI)
S100a11 nd nd + GPI
S100a16 + + +
S100b + + +
Sdf4 + + +
Slc25a12 + mtx + + ++
Slc25a23 + + +
Slc25a25 + dorsal + (< than S) nd
Sparc + + ++ vessels and pia
Sparcl1 + + + GPE>GPI
Spna2 + + +
Spock1 + vm + +
Spock2 + + ++
Spock3 +++ + (+)
Sri spa+ spa + spa+
Stim1 + + +
Stim2 + + nd
Tesc ++ ++ nd
Usp32 (+) (+) (+)
Utrn + + nd
Vsnl1 nd (+) + GPE
1500003O03Rik + + +
4732418C07Rik + + +
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Table 6. EF-hand family genes expressed in the hippocampus. The table lists the EF-hand genes showing a detectable expression in the hippocampal
formation (Ammon’s horn region CA1, 2, 3, dentate gyrus and the interneuron-rich Stratum oriens), according to the ISH-images of the ABA-database.
An additional column indicates other interneuron-rich regions (cerebellum, olfactory bulb) expressing the same genes. nd: no expression detected;
EPL: external plexiform layer; RT: reticular nucleus of the thalamus
Gene name Expression level Detailed expression in CA
ﬁelds
Expression in
dentate gyrus
Expression
in stratum
oriens
Expression in interneuron-rich
areas comments
Actn1 Ubiquitous
strong
Pyramidal cells CA1-2-3 Granular cells nd
Actn3 Ubiquitous weak
to moderate
Pyramidal cells CA1-2-3, hylus Granular cells nd
Actn4 Ubiquitous weak String of cells in CA1-2-3 String of cells in
DG
nd
Cabp1 Patterned String of cells in CA3 and hylus
(weak), CA1-2: nd
nd nd
Cabp4 Ubiquitous weak
to moderate
String of cells in CA1-2-3 String of cells in
DG
nd
Cabp5 Ubiquitous weak String of cells in CA1-2-3 String of cells in
DG
nd
Cabp7 Patterned Pyramidal cells in CA1-2-3 Granular cells nd
Calb1 Patterned Pyramidal cells CA1, CA2-3:
nd
Granular cells
DG (strong)
+ Purkinje, periglomerular OB,
sparse interneurons
Calb2 Patterned Scattered neurons Scattered
neurons
+ Glomerular cells OB,
periglomerular OB, EPL, sparse
interneurons
Calm1 Ubiquitous
strong
Pyramidal cells CA1-2-3, hylus Granular cells,
po
+
Calm2 Ubiquitous
strong
Pyramidal cells in CA1-2-3,
hylus
Granular cells,
po
+
Calm3 Ubiquitous
moderate to
strong
Pyramidal cells in CA1-2-3 Granular cells nd
Calu Ubiquitous weak String of cells in CA1-2-3 String of cells in
DG
nd
Capn1 Ubiquitous weak String of cells in CA1-2-3 and
hylus
String of cells in
DG
nd
Capn2 Ubiquitous weak String of cells in CA1-2-3 and
hylus
String of cells in
DG
nd
Capn3 Ubiquitous weak String of cells in CA1-2-3 and
hylus
String of cells in
DG
nd
Capn10 Ubiquitous weak String of cells in CA1-2-3 String of cells in
DG
nd
Capns1 Patterned Pyramidal cells CA1-2-3 and
hylus (strong),
Granular cells
(moderate), po
(strong)
+ Rare molecular layer CBX, RT
faint, periglomerular OB, EPL,
sparse interneurons
Cbara1 Ubiquitous
moderate to
strong
Pyramidal cells CA1-2-3 and
hylus
Granular cells nd
Cbl Ubiquitous weak Pyramidal cells CA1-2-3 Granular cells nd
Cblb Patterned Sparse cells in CA3 (weak),
CA1-2: nd
Granular cells
(moderate)
nd
Cetn2 Ubiquitous weak String of cells in CA1-2-3 and
hylus
String of cells in
DG
+
Cetn3 Ubiquitous weak String of cells in CA1-2-3 and
hylus
String of cells in
DG
nd
Cgref1 Patterned Sparse cells in CA3 (weak),
CA1-2: nd
nd nd
Cib2 Ubiquitous weak Pyramidal cells CA1-2-3 Granular cells nd
Dgka Patterned Pyramidal cells CA3 (weak),
CA1-2: nd
Granular cells
(weak)
nd
Dgkb Patterned Pyramidal cells CA1-3
(strong), CA2 (weak), and
hylus
Granular cells
(moderate)
nd
Dgkg Ubiquitous
strong
Pyramidal cells in CA1-2-3,
hylus (weak)
Granular cells +
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Table 6 (continued)
Gene name Expression level Detailed expression in CA
ﬁelds
Expression in
dentate gyrus
Expression
in stratum
oriens
Expression in interneuron-rich
areas comments
Drp2 Ubiquitous
strong
Pyramidal cells CA1-2-3 Granular cells nd
Dtna Patterned Pyramidal cells CA1-2-3
(moderate)
Granular cells
(strong)
+ Periglomerular OB, EPL
Dtnb Ubiquitous
strong
Pyramidal cells CA1-2-3 Granular cells +
Efcab1 Ubiquitous weak String of cells in CA1-2-3 String of cells in
DG
nd
Efcab4a Ubiquitous weak String of cells in CA1-2-3 String of cells in
DG
nd
Efcab12 Patterned String of cells in CA1 (weak),
CA2-3: nd
String of cells in
DG (weak)
nd
Efha2 Patterned String of cells in CA1-2-3
(weak)
nd nd
Efhb Ubiquitous
moderate
Pyramidal cells in CA1-2-3 Granular cells nd
Efhd2 Ubiquitous weak Scattered cells in CA1-2-3,
hylus
Scattered cells
in DG
+
Ehd1 Patterned Pyramidal cells CA1-2-3
(weak)
Granular cells
(moderate)
nd
Ehd2 Ubiquitous weak String of cells in CA1-2-3 String of cells in
DG
nd
Ehd3 Patterned Pyramidal cells in CA2
(strong), CA1-3 and hylus
(weak)
Granular cells
(strong)
nd
Eps15 Patterned Pyramidal cells CA1-2-3
(strong)
Granular cells
(moderate)
+ Molecular layer CBX, RT,
periglomerular OB, EPL, layer 2
Eps15l1 Ubiquitous weak String of cells in CA1-2-3 String of cells in
DG
nd
Fkbp9 Ubiquitous weak Pyramidal cells in CA1-2-3 Granular cells nd
Fkbp10 Ubiquitous weak Pyramidal cells in CA1-2-3 Granular cells nd
Fstl1 Ubiquitous weak String of cells in CA1-2-3 String of cells in
DG
+
Fstl4 Ubiquitous weak String of cells in CA1-2-3 String of cells in
DG
nd
Fstl5 Patterned Scattered cells in CA3 and
hylus, CA1-2: nd
nd nd
Gca Patterned Pyramidal cells CA1 (weak),
CA2-3: nd
nd nd
Gpd2 Ubiquitous
moderate to
strong
Pyramidal cells in CA1-2-3 Granular cells nd
Guca1b Ubiquitous weak String of cells in CA1-2-3 String of cells in
DG
+
Hpca Ubiquitous
strong
Pyramidal cells CA1-2-3
(strong), and hylus (weak)
Granular cells nd
Hpcal1 Ubiquitous weak String of pyramidal cells String of
Granular cells
nd
Hpcal4 Ubiquitous
moderate to
strong
Pyramidal cells in CA1-2-3 Granular cells nd
Itsn1 Ubiquitous
moderate
Pyramidal cells in CA1-2-3 Granular cells +
Itsn2 Ubiquitous weak String of cells in CA1-2-3 String of cells in
DG
nd
Kcnip1 Ubiquitous weak Scattered interneurons in the
whole hippocampus
Few sparse
cells (weak)
+
Kcnip2 Ubiquitous
moderate
Pyramidal cells in CA1-2-3 Granular cells nd
Kcnip3 Ubiquitous
moderate
Pyramidal cells in CA1-2-3 Granular cells nd
(continued on next page)
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Table 6 (continued)
Gene name Expression level Detailed expression in CA
ﬁelds
Expression in
dentate gyrus
Expression
in stratum
oriens
Expression in interneuron-rich
areas comments
Kcnip4 Ubiquitous weak
to moderate
Pyramidal cells CA1
(moderate), CA2-3 (weak)
Granular cells nd
Lcp1 Ubiquitous
moderate
Pyramidal cells in CA1-2-3 Granular cells +
Letm1 Ubiquitous weak Pyramidal cells in CA1-2-3,
hylus
String of cells in
DG
nd
Lpcat2 Ubiquitous weak String of cells in CA1-2-3 String of cells in
DG
nd
Macf1 Ubiquitous
moderate
Pyramidal cells CA1-2-3
(moderate), hylus (weak)
Granular cells +
Mcfd2 Ubiquitous
moderate
Pyramidal cells CA1-2-3
(moderate, hylus (weak)
Granular cells nd
Myl1 Ubiquitous weak Pyramidal cells in CA1-2-3 Granular cells nd
Myl6 Ubiquitous
strong
Pyramidal cells in CA1-2-3 Granular cells +
Mylpf Patterned String of cells in CA1-2-3
(weak)
nd nd
Ncald Patterned Pyramidal cells CA3 (strong),
CA2 (low), CA1 isolated cells
Granular cells
(strong)
+ RT, periglomerular OB,
interneurons basal ganglia
Ncs1 Patterned Pyramidal cells CA3 (strong),
CA1-2: sparse cells
Granular cells
(strong)
+ Hylus, molecular layer CBX, RT,
periglomerular OB
Necab1 Patterned
(strong in
entorhinal
cortex)
Few sparse cells Few sparse
cells
+ NRTH, periglomerular OB
Necab2 Patterned
(strong in
entorhinal
cortex)
Pyramidal cells in CA2
(strong), sparse cells in CA3
(weak), CA1: nd
Sparse cells in
DG
+ Periglomerular OB
Necab3 Patterned Few pyramidal cells in CA3
(weak), CA1-2: nd
String of cells in
DG
nd
Nin Ubiquitous
moderate to
strong
Pyramidal cells in CA1-2-3 Granular cells nd
Nkd1 Ubiquitous weak String of cells in CA1-2-3 String of cells in
DG
nd
Nkd2 Patterned Only pyramidal cells in CA3 nd nd
Nucb1 Ubiquitous weak String of cells in CA1-2-3 String of cells in
DG
nd
Nucb2 Ubiquitous weak String of cells in CA1-2-3 String of cells in
DG
nd
P4htm Ubiquitous
moderate
Pyramidal cells in CA1-2-3 Granular cells nd
Pdcd6 Ubiquitous weak
to moderate
Pyramidal cells in CA1-2-3 Granular cells nd
Pef1 Ubiquitous
moderate
Pyramidal cells in CA1-2-3 Granular cells nd
Pkd2 Ubiquitous weak
to moderate
String of cells in CA1-2-3 String of cells in
DG
+
Plcg1 Ubiquitous
moderate
Pyramidal cells in CA1-2-3 Granular cells +
Plch2 Patterned Pyramidal cells in CA1-2-3
(strong)
Sparse
Granular cells,
strong in po
+, hylus DG, molecular layer CBX, RT
Pls3 Patterned Pyramidal cells in CA1-2-3
(strong), hylus
Granular cells
(moderate), po
nd
Ppp2r3c Ubiquitous weak String of cells in CA1-2-3 String of cells in
DG
nd
Ppp2r3d Ubiquitous weak String of cells in CA1-2-3 String of cells in
DG
nd
Ppp3r1 Ubiquitous Pyramidal cells in CA1-2-3 Granular cells nd
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Table 6 (continued)
Gene name Expression level Detailed expression in CA
ﬁelds
Expression in
dentate gyrus
Expression
in stratum
oriens
Expression in interneuron-rich
areas comments
strong
Prkcsh Ubiquitous
moderate
Pyramidal cells in CA1-2-3 Granular cells,
po
+
Pvalb Patterned Few sparse cells Few sparse
cells
+ Molecular layer CBX, RT,
periglomerular OB
Rab11ﬁp3 Ubiquitous
strong
Pyramidal cells in CA1-2-3 Granular cells +
Rab11ﬁp4 Ubiquitous
strong
Pyramidal cells in CA1-2-3 Granular cells +
Rasgrp1 Patterned Pyramidal cells in CA1-2-3
(strong), hylus (weak)
Few sparse
cells (weak)
nd
Rcn2 Ubiquitous
moderate
Pyramidal cells in CA1-2-3 Granular cells +
Rcvrn Ubiquitous weak Pyramidal cells in CA1-2-3 Granular cells nd
Reps1 Patterned Pyramidal cells in CA1-2-3
(stronger in CA1), hylus cells
(weak)
Granular cells
(moderate)
+ RT, periglomerular OB
Reps2 Ubiquitous
moderate to
strong
Pyramidal cells in CA1-2-3 Granular cells +
Rhbdl3 Ubiquitous
moderate
Pyramidal cells in CA1-2-3 Granular cells +
Rhot1 Ubiquitous
moderate
Pyramidal cells in CA1-2-3 Granular cells nd
Rhot2 Ubiquitous
strong
Pyramidal cells in CA1-2-3 Granular cells +
Ryr1 Patterned Pyramidal cells in CA2
(strong), string of cells in CA1-
3 (weak)
Granular cells
(strong)
+, EPL, periglomerular OB
Ryr2 Ubiquitous
strong
Pyramidal cells in CA1-2-3 Granular cells +
S100a10 Ubiquitous weak String of cells in CA1-2-3 String of cells in
DG
+
S100a11 Ubiquitous weak String of cells in CA1-2-3 String of cells in
DG
nd
S100a16 Ubiquitous weak Scattered cells in CA1-2-3 Scattered cells
in DG
+
S100b Patterned Pyramidal cells in CA2
(moderate), CA1-3: nd
Scattered cells
in DG
nd
Scgn Ubiquitous weak String of cells in CA1-2-3 String of cells in
DG
nd
Sdf4 Ubiquitous
moderate
Pyramidal cells in CA1-2-3 Granular cells +
Slc25a12 Ubiquitous
strong
Pyramidal cells in CA1-2-3,
hylus
Granular cells +
Slc25a23 Ubiquitous
moderate to
strong
Pyramidal cells in CA1-2-3 Granular cells +
Slc25a25 Ubiquitous
moderate
Pyramidal cells in CA1-2-3 Granular cells +
Smoc2 Patterned Pyramidal cells in CA3, CA1-2:
nd
Granular cells nd
Sparc Patterned Scattered cells (weak) (glial
cells)
Scattered cells
in DG
+ Molecular layer CBX, RT,
periglomerular OB. (Ependyma,
pia, capillaries)
Sparcl1 Ubiquitous
moderate to
strong
Scattered cells (glial cells and
neurons)
Granular cells
(strong), po
+
Spna2 Ubiquitous
strong
Pyramidal cells in CA1-2-3 Granular cells +
Spock1 Patterned Pyramidal cells in CA3 Scattered +, Golgi/Lugaro, RT, periglomerular
(continued on next page)
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Three members of the EF-hand gene family (Cabp1,
Spock1 and Spock3) appear as speciﬁc markers of
cerebellar interneurons in the publication by (Schilling
and Oberdick, 2009).
Expression patterns of the of the EF-hand family
genes in the mesencephalon and myelencephalon
In the periaqueductal gray (PAG), a few genes are highly
expressed in the Edinger–Westphal nucleus (EW) (Nucb2
and Rcn1), or the Nucleus of Darkschewitz (Itsn1 and
Reps2). Patchy, interesting new patterns of labeling
seemingly not restricted to the classical functional
columns of the PAG (Bandler and Shipley, 1994) were
also seen for Kcnip3, Nin and Slc25a25.
Detailed expression pattern of the Neuronal Calcium
Sensor family proteins neurocalcin-d and
hippocalcin-like 4
A particular attention was paid to two members of the
NCS family, neurocalcin-d (Ncald) and hippocalcin-like 4
(Hpcal4), which also include the following genes: Ncs1,
Vsnl1, Hpcal1, Hpca, Guca1a, Guca1b, Rcvrn, and
Kcnip1 to 4. The NCS family proteins bind Ca2+ with
high aﬃnities, undergo conformational changes and
interact with and regulate other proteins, leading to
changes in physiological functions including regulation
of neurotransmitter release, regulation of cell-surface
receptors and ion channels, control of gene
transcription, cell growth and survival (Burgoyne, 2004;
McCue et al., 2010). We performed immunostaining
experiments for Ncald and Hpcal4, for which protein
expression data in rodent brain are missing in the
literature. In both cases, when comparing mRNA (ABA
data/our ISH experiment) and protein expression patterns
(our immunostaining experiment), we found a good
correspondence.
Sites of Hpcal4 protein expression (Table 2, Fig. 8)
include the main olfactory bulb (granular and mitral
cells) (Fig. 8A, B), the anterior olfactory nucleus (AON),
the piriform area, the striatum (caudoputamen (CP),
nucleus accumbens, lateral septal nucleus), the cerebral
cortex (Fig. 8C), the bed nuclei of the stria terminalis,
the thalamus (strong expression in the paraventricular
nucleus, sparsely located cells in the nucleus of
reuniens and central medial nucleus) (Fig. 8C), the
hypothalamus (weak expression in sparse cells in
several hypothalamic nuclei), the hippocampus (strong
expression in Ammon’s horn regions CA1 lateral, CA3
pyramidal layer, and in granular cells in the dentate
gyrus) (Figs. 7C and 8C, D), the midbrain (strong
expression in ventral tegmental area (VTA) and dorsal
raphe´ nucleus, and sparse cells in inferior colliculus and
midbrain reticular nucleus) (Fig. 8G), the pons (strong in
locus coeruleus (LC), superior central raphe´ nucleus
(CS), parabranchial nucleus (PB), and sparse cells in
pontine reticular nucleus (PRN)) (Fig. 8E), the medulla
Table 6 (continued)
Gene name Expression level Detailed expression in CA
ﬁelds
Expression in
dentate gyrus
Expression
in stratum
oriens
Expression in interneuron-rich
areas comments
(strong), scattered cells in
CA1-2 and hylus
granular cells,
po (strong)
OB
Spock2 Ubiquitous
strong
Pyramidal cells in CA1-2-3 Granular cells +
Spock3 Patterned Pyramidal cells in CA3
(strong), string of cells CA1-2
Granular cells +, CBX, faint RT, periglomerular OB
Stim1 Ubiquitous
moderate to
strong
Pyramidal cells in CA1-2-3,
hylus
Granular cells,
po
+
Stim2 Ubiquitous
strong
Pyramidal cells in CA1-2-3 Granular cells,
po
nd
Tesc Ubiquitous
moderate to
strong
Pyramidal cells in CA1-2-3 Granular cells nd
Tnnc2 Ubiquitous weak String of cells in the pyramidal
cell layers
nd nd
Usp32 Ubiquitous weak
to moderate
Pyramidal cells in CA1-2-3
(moderate), hylus cells (weak)
Sparse granular
cells
nd
Vsnl1 Patterned Pyramidal cells CA1-3
(moderate), hylus cells
(strong)
Sparse granular
cells
+, Periglomerular OB
Zzef1 Weak Sparse cells in CA1-2-3 Sparse granular
cells
nd
1500003O03Rik Ubiquitous
moderate to
strong
Pyramidal cells in CA1-2-3 Granular cells nd
4732418C07Rik Ubiquitous weak
to moderate
Pyramidal cells in CA1-2-3 Granular cells +
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Table 7. EF-hand family genes expressed in the Amygdala. List of genes expressed in the various amygdalar subdivisions: CEA: central amygdalar
nucleus; MEA: medial amygdalar nucleus; LA: lateral nucleus; BMA: basomedial amygdalar nucleus; BLA: basolateral amygdalar nucleus; CO: Cortical
amygdalar area; PA: posterior amygdalar nucleus. Indications: +++: strong positive; ++: moderate positive; +: positive; (+): faint or not observed
on all sections; nd: not detected; ubi: ubiquitous; sca: scattered cells; spa: sparse cells. Other abbreviations: BLAa: basolateral amygdalar nucleus,
anterior part; BLAv: basolateral amygdalar nucleus, ventral part; BMAa: basomedial amygdalar nucleus, anterior part; BMAp: basomedial amygdalar
nucleus, posterior part; CEAl: central amygdalar nucleus, lateral part; COAPm2: cortical amygdalar area, posterior part, medial zone; EPv: endopiriform
nucleus ventral part; IA: intercalated amygdalar nucleus; NLOT: nucleus of the lateral olfactory tract
Gene name CEA MEA LA BMA BLA COA PA
Actn1 + ++ + ++
Actn4 (+) + + + (+) ++
Calb1 +spa
Calb2 +++
Calm1 + + + + + +++
Calm2 + + + + + +++
Calm3 + + ++
Capn2 (+) (+) (+) (+) (+) (+)
Capn 8 (+) (+) (+) (+) (+) (+)
Capns1 + + + + + +
Cbara1 +
Cetn2 + + + + + +
Cetn3 +
Cgref1 + +
Dgkb + + + + + +
Dgkg + + + + + +
Drp2 + + + + + +
Dtna + + + + + +
Dtnb + + + + + +
Efcab1 (+) (+) (+) (+) (+) (+)
Efhd2 + + + + ++ +
Ehd3 ++ ++BMAp
Eps15 ++BMAp
Eps15l1 + + + + + +
Fstl1 +
Fstl4 +
Fstl5 +
Gpd2 + +
Guca1b + + + + + +
Hpca + + + + + +
Hpcal1 + +
Hpcal4 + + + + + + +
Itsn1 + + + +
Kcnip1 sca. sca. sca. sca. sca. sca. spa.
Kcnip2 + + + + + + +
Kcnip3 + + + + + + +
Lcp1 (+)
Letm1 + + + + + + +
Lpcat2 + +
Macf1 + + + + + + +
Mcfd2 + + + + + + +
Myl1 + + + + + + +
Myl4 + +BLAv, BMAp, EPv
Myl6 + + + + + + +
Ncald + + + + ++ + +
Ncs1 + + + + + + +
Necab1 ++BMAa +BLAa
Necab2 ++ ++
Necab3 + +
Nin + + + + + + +
Nucb1 +
Nucb2 + +
P4htm + + + + + + +
Pdcd6 +
Plcg1 + + + + + + +
Plch2 + +
Plcz1 +
(continued on next page)
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(nucleus of the solitary tract) (Fig. 8F). A weak
immunostaining staining is also observed in the
cerebellum although ABA ISH images show no mRNA
expression above the detection level (not shown).
Ncald protein expression is more widespread (Figs. 6,
7, 9 and 10), including the main olfactory bulb (strong in
glomerula layer of the olfactory bulb (gl) and granular
layer of the olfactory bulb (gr), sparse cells in mitral
cells layer, olfactory bulb (mi) and outer plexiform layer,
olfactory bulb (opl)) (Figs. 9A and 10), the AON
(Fig. 9B), the cerebral cortex (Fig. 9C), the striatum
(strong in lateral septal nucleus, septohippocampal
nucleus, few isolated cells in nucleus accumbens,
caudoputamen and medial septal nucleus) (Fig. 9C), the
thalamus (widespread thalamic expression, stronger in
medial habenula, paraventricular nucleus, antero-dorsal
and antero-ventral nuclei of the thalamus) (Fig. 9D), the
hypothalamus (ubiquitous), the hippocampus (mainly
CA3 sp and DG sg, strong in the Fasciola cinerea)
(Figs. 6A and 7A, 9E), the midbrain (sparse cells
throughout, stronger in the dorsal raphe´ nucleus)
(Fig. 9K), the pons (sparse cells throughout, stronger in
the LC and tegmental reticular nucleus (TRN)) (Fig. 9L),
the medulla (weak staining in sparse cells throughout,
stronger in the nucleus of the solitary tract), the
cerebellum (granular layer) (Fig. 9I). We detected no
protein in the reticular thalamic nucleus, although the
mRNA is present according to ABA. From co-
immunostaining experiments in the MOB with Ncald and
the three classical EF-CaBPs, we obtained the following
data (Fig. 10): (1) In the outer plexiform layer: co-
expression of Ncald in all GABAergic interneurons
expressing Parv. In addition, Ncald also stains a
signiﬁcant population of Parv-negative cells in the opl.
Table 7 (continued)
Gene name CEA MEA LA BMA BLA COA PA
Pls3 +BMAp +BLAa +
Ppp2r3c + + + + + + +
Ppp2r3d + + + + + + +
Ppp3r1 + + + + + + +
Prkcsh + + + + + + +
Pvalb (+) + + + + + +
Rab11ﬁp3 + + + + + + +
Rab11ﬁp4 +
Rasgrp1 + + + ++ + + +
Rcn1 ++ +++COApm2
Rcn2 + + + + + + +
Reps1 + + + +
Reps2 (+) (+) (+) + ++ + +
Rhbdl3 + + + + + + +
Rhot1 + + (+) (+)
Rhot2 +BLAp
Ryr1 + (+)
Ryr2 + + + + + + +
S100a10 +
S100a11 + + + + + + +
S100a16 (+) (+) (+) (+) (+) (+) (+)
S100b +CEAI, IA +BMA
Scgn (+) (+) (+) (+) (+) (+) (+)
Sdf4 + + + + + + +
Slc25a12 + + + + + + +
Slc25a23 + + + + + + +
Slc25a25 (+) (+) (+) (+) (+) (+) (+)
Smoc1 +COApm2/3, PAA
Smoc2 +PAA
Sparc + + + + + + +
Sparcl1 + + + + + + +
Spna2 + + + + + + +
Spock1 ++ + ++ ++ ++ NLOT
Spock2 ubi ubi ubi ubi ubi ubi ubi
Spock3 (+) (+) (+) (+) (+) (+) (+)
Sri spa spa spa spa spa spa spa
Stim1 + + + + + + +
Stim2 + + + + + + +
Tesc + + + + + + +
Usp32 (+) (+) (+) (+) (+) (+) (+)
Utrn (+) (+) (+) (+) (+) (+) (+)
Vsnl1 (+) (+) (+) (+) (+) (+) (+)
1500003O03Rik + + + + + + +
4732418C07Rik + + + + + + +
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Ncald also co-exists with CalR in the opl. (2) In the
glomerular layer: Ncald-immunoreactive neurons are
mostly CalR-positive and Calb-D28K-negative. (3) In the
mitral and granular layers: little or no coexistence with
CalR and Ncald can be observed. Analyzing co-
expression with these three EF-hand proteins in the
cerebral cortex, we found no co-expression of Hpcal4
with Parv and CalR, whereas Hpcal4 is expressed in
Calb-D28K immunoreactive neurons in the upper
cortical layers (2/3), but not in scattered neurons in the
lower layers (5/6). For Ncald, we did not observe co-
expression with any of the three markers in the cerebral
cortex (data not shown).
Expression pattern of Tescalcin
Tescalcin, a member of the calcineurin homologous
protein family, is expressed both in embryonic and adult
mouse (Guttierez-Ford et al., 2003; Bao et al., 2009).
Based on ABA ISH images, the Tesc mRNA is expressed
in the following brain areas (see also the diﬀerent Tables):
olfactory bulb (weak expression in gr layer); cerebral cor-
tex (layers 2/5/6); striatum; strong expression in the hip-
pocampus; little or no expression in the HY, excepting
the suprachiasmatic nucleus (SCH) and sparse cells in
the zona incerta (ZI); thalamus (strong in medial habenula
(MH), weaker in anterodorsal thalamic nucleus (AD));
midbrain (moderate to strong expression in red nucleus
(RN), oculomotor nucleus (III), midbrain trigeminal
nucleus (MEV), weaker in inferior colliculus (IC) and dor-
sal raphe´ nucleus (DR)); pons (strong expression in motor
nucleus of trigeminal nerve (V), PRN, TRN, weaker in
pontine gray (PG), nucleus of the lateral lemniscus
(NLL), nucleus of the trapezoid body (NTB) and principal
sensory nucleus of the trigeminal (PSV)); medulla
(expression scattered throughout the medulla, stronger
in several nuclei including abducens nucleus (VI), facial
motor nucleus (VII), hypoglossal nucleus (XII), nucleus
Fig. 6. Co-expression of Ncald and Pls3 with Pvalb in the hippocampus. (A–D) In-situ hybridization to Ncald (A, C) and Pvalb (B, D) on adjacent
coronal mouse brain sections. Panels C to D are higher magniﬁcations of panels A and B, respectively. Black arrows point to neurons co-expressing
both genes in CA1sp and so. Some cells (white arrows) are only Pvalb, respectively Ncald positive. (E–K) In situ hybridization results for Pls3 (E, H,
J) and Pvalb (G, I, K) on adjacent coronal mouse brain sections. Panel F shows Pls3 ISH image taken from the ABA. Panels H–K are higher
magniﬁcations of panels E and G. Arrows point to neurons co-expressing both genes, in dentate gyrus sg (granular cell layer) and po (polymorph
cell layer), and in the pyramidal layer of regions CA1/2/3.
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ambiguus (AMB), lateral reticular nucleus (LRN)); cere-
bellum (gr and Pu layers). At the protein level, similar
expression patterns were observed, in particular the
areas of stronger expression sites, including the striatum,
hippocampus, medial habenula and several well-deﬁned
nuclei in the midbrain, pons and medulla (MEV, NTB, V,
VII) (Fig. 11).
DISCUSSION
Attempts to understand the structural complexity of the
brain by a systematic ordering of its manifold neuronal
populations have involved the instrumentation of
several, mostly independent, criteria, such as cell
morphology, cellular connectivity, electrophysiological
properties and the expression of speciﬁc markers.
Implementation of the latter system of categorization
led, for example, to the identiﬁcation of glutamatergic
and GABAergic interneurons on the basis of their
expression of the eponymous neurotransmitters
(Seguela et al., 1984; Storm-Mathisen and Ottersen,
1987; Somogyi and Klausberger, 2005; DeFelipe et al.,
2013). The neuropeptides (e.g., cholecystokinin, VIP
and somatostatin) represent another group of successful
markers. However, in some instances, detectable levels
of the peptide in the cell body cannot be achieved other
than by a colchicine-induced inhibition of its cytoplasmic
transport. An exception worthy of note is the peptide
hypocretin/orexin (Peyron et al., 1998), which is
exclusively expressed in a circumscribed hypothalamic
neuronal population. Antibodies against hypocretin/orexin
have been employed not only to elucidate the morphologi-
cal features of this sub-population of neurons but also to
study their connectivity and hence putative function within
the neuronal ensemble.
In the Introduction section, four members of the
superfamily of EF-CaBPs were named as being useful
neuronal markers [Calb-D28K, CalR, Parv (Baimbridge
et al., 1992; Schwaller, 2009, 2010) and Scgn (Alpar
et al., 2012)]. This attribute partially reﬂects their high
cellular concentration and preferentially cytosolic dis-
tribution. Immunohistochemical staining after treatment
with antibodies against these CaBPs has permitted a
delineation of the soma, the dendrites, the axon and the
endings of the targeted cells. The use of antibodies
against these four EF-CaBPs has been helpful in
revealing (1) speciﬁc subdivisions of the brain [e.g., the
patch-matrix mosaic in the basal ganglia using antibodies
against Calb-D-28k (Gerfen et al., 1987)] and the
extended amygdala using anti-Scgn antibodies (Mulder
et al., 2010)]; (2) new’’ brain nuclei, such as the hypotha-
lamic Parv-immunoreactive PV1/Foxb1-nucleus (Celio,
1990; Girard et al., 2011; Meszar et al., 2012; Bilella
et al., 2014)]; and (3) a rare and ‘‘new’’ type of disinhibi-
tory interneurons using CalR antibodies (Gulyas et al.,
1992)]. These four EF-CaBPs alone have had an impor-
tant impact on neuroscience, and we suspected that the
EF-hand family contains other ‘‘rare pearls’’ and that it is
under-represented among the accepted neuronal
markers. For example, the S100A6 protein (also called
calcyclin) was identiﬁed very recently as a speciﬁc marker
for neural stem cells and astrocyte precursors in the
hippocampus (Yamada and Jinno, 2014). It was for this
reason that the meticulous, data-mining analysis of the
in-situ-hybridization images in the ABA was undertaken.
Our primary goal was to establish a repertoire of
Fig. 7. Ncald protein, but not Hpcal4, is co-expressed in Parv-immunoreactive neurons in the hippocampus. (A–B) Ncald immunoreactivity in the
hippocampus. Co-expression with Parv is visible in some neurons in the pyramidal and oriens layers (so) of the CA1 (yellow arrows), while some
other cells are only Parv (red arrows), respectively Ncald positive (white arrows). Panel (B) is a merged image with both Ncald (green) and Parv
(red) immunostainings. (C–E) Hpcal4 (C) and Parv (E) immunostaining in the CA1/2/3 regions. Hpcal4 is not detected in Parv immunoreactive
neurons (marked with arrows), both in the pyramidal layer and stratum oriens. Panel E is the merge image. (For interpretation of the references to
colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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expression proﬁles in the murine brain for the genes
encoding the EF-CaBPs, with a view to aﬀording a basis
for more specialized experimental investigations. Our
second goal was to ascertain which of the 249
EF-CaBPs might serve as putative neuronal (or glial) mar-
kers. Actually, notwithstanding the suggestivity of the
data, the mRNA-expression proﬁle of a particular gene
as reported in the ABA is no guarantee that an antibody
against the corresponding encoded protein will be a use-
ful neuro-anatomical tool. In-situ-hybridization yields a
signal that is conﬁned to the cell bodies; it elicits no infor-
mation appertaining to the precise expression proﬁle of
the protein within a neuron. Moreover, one cannot dis-
count regulation at the translational and/or post-transla-
tional levels. Consequently, in-situ-hybridization signals
do not necessarily correspond to the protein-expression
levels. This is the case with S100A6; although the protein
is detected by immunostaining in the neuronal precursors
of the subgranular zone of the DG (Yamada and Jinno,
2014), no ISH signal is documented in the ABA.
Discrepancies might also exist for genes that encode
various extracellular-matrix proteins, for example Smoc1
and 2, Sparc, Sparcl, Spock1, 2 and 3. Although the cell
bodies are revealed by ISH, the proteins themselves inﬁl-
trate the extracellular space, partially accounting for the
perineuronal net around distant neurons, such as was
shown for tenascin-R (Wintergerst et al., 2001). As is
revealed in Table 2, most of the EF-CaBP-encoding
genes are expressed in numerous areas, mainly in neu-
rons but sometimes also in glial cells (S100b, S100A16,
4732418C07Rik), choroid plexus (Actn1) or meninges
(Sparc). Those that are ubiquitously expressed can be
distinguished from those that manifest a more restricted
and complex pattern of expression, with elevated levels
in only a few, well-deﬁned areas. The latter members
are considered to be the most promising marker candi-
dates (Table 2, 3d column). Notable among these, are
neurocalcin-d, hippocalcin-like 4 or tescalcin. For these
members, the protein-expression patterns were analyzed
immunohistochemically. On the basis of the cytoplasmic
staining patterns that were thereby revealed, antisera
against these three EF-CaBPs might indeed prove to be
Fig. 8. Hpcal4 protein expression in the mouse brain. (A) Hpcal4 staining is detected in the main olfactory bulb (MOB), both in mitral (mi) and
granular (gr) layers. (B) Note that Hpcal4 immunoreactivity is detected mostly in CalR-negative neuronal populations, but also exists in some CalR-
positive ones. (C) Staining is also detected in the cerebral cortex (CTX) (stronger in layers 2/3 and 5/6), in the paraventricular nucleus of the
thalamus (PVT) and the hippocampus (HPF). (D) Double immunostaining for Calb-D28K (red) and Hpcal4 (green). A large contingent of granule
cells of the DG expresses both proteins (yellow arrows). Notice that Calb-D28K immunoreactivity is of much lower intensity in CA1 compared to DG.
Red arrow points to Calb-D28K immunoreactivity in axonal projections from cell bodies localized in DG, while Hpcal4 antibody stains CA3 pyramidal
cell bodies (green arrow). White arrows delimitate the CA2 region, highlighting a fainter Hpcal4 staining. (E) The locus coeruleus (LC) expresses a
strong Hpcal4 signal. Lower staining intensity can be detected in the pontine central gray (PCG; E), the nucleus of the solitary tract (NTS; F), the
dorsal raphe´ nucleus (DR; G), the superior central raphe´ nucleus (CS; G). In panel F, arrow points to staining in the lateral-most region of the spinal
nucleus of the trigeminus, interpolar part (SPVIl). In panel I, higher magniﬁcation of PAG neurons shows that Hpcal4 immunoreactivity can be
detected both in the soma and dendrites. (H) Anti-Hpcal4 antiserum detects a band at 25 kDa in mouse brain extract. Scale bar = 500 lm, unless
diﬀerently speciﬁed. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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Fig. 9. Ncald protein expression in the mouse brain. (A) Ncald staining of moderate intensity is detected in the main olfactory bulb (MOB). (B)
Staining in CTX layers 2/3 (pCTX: prefrontal cortex) and anterior olfactory nucleus (AON). (C) Labeling of the lateral septal nucleus (LS) and
absence of labeling in the upper layers of the CTX. (D) Thalamus with labeling in the medial habenula (MH), paraventricular nucleus (PVT), central
medial nucleus of the thalamus (CM) and rhomboid nucleus (RH). (E) Hippocampus with strong labeling in DG granular layer and CA3 pyramidal
layer, low intensity in CA2 (delimitated by white arrows), and present only in very few cells in CA1 (stratum oriens layer). (F) Same section as in (E),
but incubated with an antibody to Calb-D28K (red). Panel G is the merged image. Ncald-immunoreactivity is detected in cell bodies in the pyramidal
cell layer of CA3, but also in neuronal projections co-stained with Calb-D28K in the stratum lucidum (slu) (arrows in panel G). Note that a large
number of granular cells in the dentate gyrus express both proteins. (H) Staining in the subiculun (SUB), highlighting Ncald immunoreactivity both in
cell bodies and neuronal processes. (I) double immunostaining for Parv (red) and Ncald (green) in the cerebellum, expressed respectively in the
molecular and granular cells layer. (J) staining in the hypothalamus with mammillary nucleus (MM) highlighted. (K) staining in the midbrain (MB)
highlighting the periaqueductal gray (PAG), the dorsal raphe´ nucleus (DR) and the superior central raphe´-nucleus (CS). (L) Weak-to-moderate
labeling of the tegmental reticular nucleus (TRN). (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web
version of this article.)
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useful for the tagging of speciﬁc neuronal populations.
Hpcal4, for example, is expressed in the cells of several
brain nuclei that are involved in the control of sleep–wake
cycles, including DR, LC, VTA, pontine central gray
(PCG) and hypothalamus (HY) (Brown et al., 2012).
Tesc shows strong expression in several brainstem nuclei
known to be involved in whisker circuits in rodents
(trigeminal nuclei MEV, V; facial motor nucleus) (Sehara
and Kawasaki, 2011; Petersen, 2014).
The mitral cells in the OB, the CA1-pyramidal cells of
the hippocampus and the cerebellar Purkinje cells,
were revealed to express between 80 (mitral- and
Purkinje-cells) and 100 (pyramidal cells) diﬀerent
EF-hand genes thereby indicating that their functional
competence greatly depends upon Ca2+. The same
may hold true also for interneurons. However, owing to
their heterogeneity and scattered distribution, the study
of these cells is more complex; for example in the
Stratum oriens of the hippocampus - a region that is
known to be populated exclusively by interneurons -,
scattered cells express 51 diﬀerent EF-CaBP-encoding
genes, which are probably localized in diﬀerent
subpopulations (Table 6). The same genes are often
expressed in interneurons that are lodged in the
periglomerular layers of the OB (16 genes), in the
external plexiform layer of the OB (ﬁve genes) and, in
the molecular layer of the CB (six genes). Particularly
promising will be the comparison with the four classical
markers Calb-D28K, CalR, Parv, Scgn with the
expression of Capns1, Eps15, Ncs1, Necab2,
Sparc, Spock1/2/3, Vsnl1 and Zzef1 proteins, which are
found in various combinations in the aforementioned
interneuron-rich regions. In the cerebral cortex, all
genes that are expressed in sparse/scattered cells in
several or all of the layers may be markers for
interneurons (48 diﬀerent genes). Sparcl1 may be a new
marker of Cajal-Retzius cells in layer 1 and Tnnc1 is
one of the only neuronal EF-CaBP-encoding gene that
is enriched in layer 4 neurons of the somatosensory
barrel cortex. Single layer markers include Cabp1 for
layer 2 and 5a whereas Sparcl1 is expressed in all
layers except number 4.
Some genes selectively reveal speciﬁc cells, nuclei or
layers in the brain, which aﬀords the unique opportunity of
investigating their development and functions by genetic
targeting and manipulation. For example, Nkd2 occurs
only in CA3-pyramidal cells and in layer-2 cells of the
piriform cortex. Myl 4 is expressed in layers 5 and 6 of
the isocortex, in the amygdala and in the ventral
pallidum. Necab3 is strongly expressed in the lateral
habenula (LH) and in the upper and the lower isocortical
layers. Pls3 occurs speciﬁcally in the endopiriform
nucleus (END) and in the claustrum. Rcn1 is expressed
speciﬁcally in the medial-posterodorsal and in layer 2 of
the cortical posterior amygdalar nucleus; it also occurs
in the Edinger–Westphal nucleus as already shown by
Fig. 10. Ncald immunoreactivity in the main olfactory bulb. Co-immunostaining experiments in the main olfactory bulb for Ncald (green) (C, F, I) and
each of the three EF-CaBPs (red): Parv (A), Calb-D28K (D) and CalR (G). Central panels (B, E, H) are merged images. Arrows in panels (B) and (C)
highlight example neurons immunoreactive for both Ncald and Parv in the outer plexiform layer (opl). Arrows in panels (H) and (I) highlight example
neurons immunoreactive for both Ncald and CalR in the opl. Notice that in both cases, a signiﬁcant proportion of Ncald-positive neurons are
negative for Parv or CalR. In the glomerular layer (gl), Ncald immunoreactivity pattern mostly overlaps with CalR (H), but not Calb-D28K (E). (For
interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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Fig. 11. Tesc protein expression in the mouse brain. (A) Immunoblotting, showing the speciﬁcity of the anti-Tesc immunoserum for 25-kDa
tescalcin protein (arrow) in mouse brain extracts. (B–L) Immunostaining experiments highlighting some preferential sites of Tesc immunoreactivity.
(B) Medial habenula (MH); (C) hippocampus (HPF); (D, J) trigeminal nucleus (MEV) (notice the co-expression with Parv, Panels (D–(E)); (G)
nucleus of the trapezoid body (NTB) (notice the co-expression with Calb-D28K, Panels (G)–(I)); (J, K) motor nucleus of the trigeminal (V); (L) facial
motor nucleus (VII). Other abbreviations: V3: third ventricle; SC: superior colliculus; PAG: periaqueductal gray; PRNr/c (pontine reticular nucleus
rostral/caudal part); PVT: paraventricular nucleus of the thalamus. Scale bar = 100 lm.
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others (Giardino et al., 2012). Fstl5 is expressed only in
the sparse population of neurons in the CA3 region [but
see also (Masuda et al., 2014)], and the SCH expresses
two genes at high levels (Nkd1 and Plch2).
A remarkable continuous, single layer of cells
expressing the six EF-hand genes Drp2, Rhbdl3, Rcvrn,
Ryr2, Sdf4 and Sri, is aligned in parallel to the Purkinje
cell layer at the edge of the granular layer, close to the
white matter. To our knowledge such cells have not
been reported in the recent literature [but see (Golgi,
1903; Cajal, 1955)] and a clariﬁcation of their identity must
await the generation of speciﬁc antibodies and the perfor-
mance of detailed immunohistochemical studies.
In conclusion, this study reports on a meticulous
analysis of the mRNA-expression proﬁles of the
EF-CaBP-encoding genes in the murine brain, which
was based on an evaluation of the in-situ-hybridization
images in the ABA. The purpose of the study was to
identify potentially useful markers for speciﬁc neurons,
as well as for speciﬁc brain nuclei, areas and layers,
and possibly also for speciﬁc functional systems.
Our ﬁndings aﬀord an insight into the organizational
complexity of the EF-CaBPs, which act as intracellular
Ca2+-sensors or buﬀers and translate short-lived
changes in the intracellular Ca2+-concentration into
meaningful cellular messages. Several investigations
have addressed the potential roles of EF-CaBPs other
than Calb-D28K, CalR and Parv in neuropathologies like
Alzheimer’s disease [Vsnl1 and Hpcal1 (Braunewell,
2012; Plc: Popovics and Stewart, 2012); Ryanodine
receptors (Del Prete et al., 2014); S100a9 (Chang et al.,
2012)], schizophrenia [Cabp1 (Bernstein et al., 2007)] or
traumatic brain injury [neuronal calpains (Saatman
et al., 2010; Liu et al., 2014)]. Thus, collecting data on this
family of Ca2+-binding proteins might also be medically
relevant, because of their crucial roles in regulating
Ca2+ homeostasis, a process perturbed in several
neurological and psychiatric diseases.
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